PL2338982T3 - Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania - Google Patents

Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania

Info

Publication number: PL2338982T3
Authority: PL; Poland
Prior art keywords: making; methods; same; umbilical cord; cells derived
Prior art date: 2003-06-27

Application number

PL10184306T

Other languages

English (en)

Inventor

Ian Ross Harris

Alexander M Harmon

Anthony J Kihm

Darin J Messina

Sanjay Mistry

Agnieszka Seyda

Chin-Feng Yi

Anna Gosiewska

Original Assignee

Depuy Synthes Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2004-06-25

Publication date

2016-01-29

2004-06-25 Application filed by Depuy Synthes Products Inc filed Critical Depuy Synthes Products Inc

2016-01-29 Publication of PL2338982T3 publication Critical patent/PL2338982T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Psychology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)

PL10184306T 2003-06-27 2004-06-25 Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania PL2338982T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US48326403P	2003-06-27	2003-06-27
EP10184306.8A EP2338982B1 (en)	2003-06-27	2004-06-25	Postpartum cells derived from umbilical cord tissue and methods of making and using the same
EP04756395.2A EP1641913B1 (en)	2003-06-27	2004-06-25	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

Publications (1)

Publication Number	Publication Date
PL2338982T3 true PL2338982T3 (pl)	2016-01-29

Family

ID=38456561

Family Applications (14)

Application Number	Title	Priority Date	Filing Date
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo

Family Applications Before (9)

Application Number	Title	Priority Date	Filing Date
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo

Country Status (8)

Country	Link
US (28)	US7510873B2 (pl)
EP (14)	EP2399990B1 (pl)
JP (7)	JP4950659B2 (pl)
AU (7)	AU2004252571C1 (pl)
CA (7)	CA2530422C (pl)
ES (14)	ES2569780T3 (pl)
PL (14)	PL1641918T3 (pl)
WO (7)	WO2005038012A2 (pl)

Families Citing this family (573)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8563232B2 (en)	2000-09-12	2013-10-22	Lifenet Health	Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US20080077251A1 (en) *	1999-06-07	2008-03-27	Chen Silvia S	Cleaning and devitalization of cartilage
US20020095157A1 (en) *	1999-07-23	2002-07-18	Bowman Steven M.	Graft fixation device combination
US6179840B1 (en)	1999-07-23	2001-01-30	Ethicon, Inc.	Graft fixation device and method
US8147824B2 (en)	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
CA2430989A1 (en) *	2000-12-06	2002-06-13	Robert J. Hariri	Method of collecting placental stem cells
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
US7311905B2 (en) *	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2796875A1 (en) *	2001-02-14	2002-08-22	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
EP2336300B1 (en) *	2001-02-14	2015-07-08	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
WO2003008535A2 (en) *	2001-07-20	2003-01-30	Technion Research And Development Foundation Ltd.	Methods of generating human cardiac cells and tissues and uses thereof
US7677565B2 (en)	2001-09-28	2010-03-16	Shuffle Master, Inc	Card shuffler with card rank and value reading capability
US20080299090A1 (en) *	2002-02-25	2008-12-04	Kansas State University Research Foundation	Use Of Umbilical Cord Matrix Cells
US7736892B2 (en) *	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20080003258A1 (en) *	2002-10-16	2008-01-03	Marcum Frank D	Composition and Method for Treating Rheumatoid Arthritis
US7824701B2 (en) *	2002-10-18	2010-11-02	Ethicon, Inc.	Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en)	2002-10-18	2004-04-22	Francois Binette	Biocompatible scaffolds with tissue fragments
AU2003298775B2 (en) *	2002-11-26	2008-07-17	Anthrogenesis Corporation	Cytotherapeutics, cytotherapeutic units and methods for treatments using them
WO2004069172A2 (en)	2003-01-30	2004-08-19	The Government of the United States of America as represented by the Department of Veterans Affairs	Multilineage-inducible cells and uses thereof
ES2351386T3 (es)	2003-02-11	2011-02-03	John E. Davies	Células progenitoras procedentes de la gelatina de wharton de cordón umbilical humano .
NZ566132A (en) *	2003-02-13	2009-09-25	Anthrogenesis Corp	Use of umbilical cord blood to treat inflammation, ParkinsonÆs disease or diabetes
US8197837B2 (en)	2003-03-07	2012-06-12	Depuy Mitek, Inc.	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
CN100377165C (zh) *	2003-04-24	2008-03-26	皇家飞利浦电子股份有限公司	无创式左心室的容积测定
US7875272B2 (en) *	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
AU2004252571C1 (en)	2003-06-27	2012-03-01	Ethicon, Incorporated	Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US8491883B2 (en) *	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US20060223177A1 (en) *	2003-06-27	2006-10-05	Ethicon Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US8226715B2 (en)	2003-06-30	2012-07-24	Depuy Mitek, Inc.	Scaffold for connective tissue repair
US10583220B2 (en)	2003-08-11	2020-03-10	DePuy Synthes Products, Inc.	Method and apparatus for resurfacing an articular surface
EP1653994B1 (en) *	2003-08-12	2009-11-25	Tigenix N.V.	Use of cxcl6 chemokine in the prevention or repair of cartilage defects
US8043614B2 (en) *	2004-03-09	2011-10-25	Ahlfors Jan-Eric W	Autogenic living scaffolds and living tissue matrices: methods and uses thereof
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
US7316822B2 (en)	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
US7682828B2 (en)	2003-11-26	2010-03-23	Whitehead Institute For Biomedical Research	Methods for reprogramming somatic cells
BRPI0417186A (pt) *	2003-12-02	2007-03-06	Celgene Corp	método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica
US7901461B2 (en) *	2003-12-05	2011-03-08	Ethicon, Inc.	Viable tissue repair implants and methods of use
JP2005168360A (ja) *	2003-12-09	2005-06-30	Olympus Corp	生体組織補填体の検査方法、装置、細胞培養容器および培養状態検査方法
US20050176139A1 (en) *	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
US20080241107A1 (en) *	2004-01-23	2008-10-02	Copland Iii John A	Methods and Compositions For Preparing Pancreatic Insulin Secreting Cells
US11395865B2 (en)	2004-02-09	2022-07-26	DePuy Synthes Products, Inc.	Scaffolds with viable tissue
EP2298862B1 (en) *	2004-03-22	2017-08-30	Mesoblast International Sàrl	Mesenchymal stem cells and uses therefor
US8221780B2 (en) *	2004-04-20	2012-07-17	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US8137686B2 (en)	2004-04-20	2012-03-20	Depuy Mitek, Inc.	Nonwoven tissue scaffold
CN101080486B (zh) *	2004-04-23	2012-05-16	佰欧益股份有限公司	多谱系祖细胞
US7622108B2 (en) *	2004-04-23	2009-11-24	Bioe, Inc.	Multi-lineage progenitor cells
US8765119B2 (en) *	2004-05-06	2014-07-01	University Of South Florida	Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells
US7794697B2 (en)	2004-06-30	2010-09-14	Abbott Medical Optics Inc.	Enhancement of lens regeneration using materials comprising polysiloxane polymers
US8802651B2 (en) *	2004-06-30	2014-08-12	Abbott Medical Optics Inc.	Hyaluronic acid in the enhancement of lens regeneration
US20060083732A1 (en) *	2004-06-30	2006-04-20	Arlene Gwon	Hyaluronic acid in the enhancement of lens regeneration
EP1789534B1 (en)	2004-08-16	2014-08-06	CellResearch Corporation Pte Ltd	Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
US20060045872A1 (en)	2004-08-25	2006-03-02	Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco	Use of adipose tissue-derived stromal stem cells in treating fistula
US8039258B2 (en) *	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20060069008A1 (en) *	2004-09-28	2006-03-30	Sanjay Mistry	Treatment of neurological deficits in the striatum or substanta nigra pars compacta
US20080038316A1 (en) *	2004-10-01	2008-02-14	Wong Vernon G	Conveniently implantable sustained release drug compositions
US7473678B2 (en)	2004-10-14	2009-01-06	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods of use thereof
US7842304B2 (en) *	2004-10-29	2010-11-30	Nexeon Medsystems, Inc.	Methods and apparatus for treating an injured nerve pathway
US11660317B2 (en)	2004-11-08	2023-05-30	The Johns Hopkins University	Compositions comprising cardiosphere-derived cells for use in cell therapy
US8017395B2 (en)	2004-12-17	2011-09-13	Lifescan, Inc.	Seeding cells on porous supports
US20060153815A1 (en) *	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
US20060166361A1 (en) *	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060171930A1 (en) *	2004-12-21	2006-08-03	Agnieszka Seyda	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
EP1831355A2 (en) *	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
WO2006071802A2 (en)	2004-12-23	2006-07-06	Ethicon Incorporated	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
EP1838842A2 (en) *	2004-12-23	2007-10-03	Ethicon, Incorporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
US20060182724A1 (en) *	2005-02-15	2006-08-17	Riordan Neil H	Method for expansion of stem cells
EP2295541B1 (en) *	2005-03-04	2016-04-27	Kyoto University	Pluripotent stem cell derived from cardiac tissue
US20060222634A1 (en) *	2005-03-31	2006-10-05	Clarke Diana L	Amnion-derived cell compositions, methods of making and uses thereof
CN103361301A (zh)	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	高度纯化来自羊膜的细胞群
US8153430B2 (en) *	2005-03-31	2012-04-10	Stemnion, Inc.	Methods related to surgery
US8999706B2 (en) *	2005-04-12	2015-04-07	The Trustees Of The University Of Pennsylvania	Methods for preparation of human hair-follicle derived multipotent adult stem cells
US20100087546A1 (en) *	2005-04-20	2010-04-08	Biogenic Innovations, Llc	Use of dimethyl sulfone (msm) to reduce homocysteine levels
WO2006113731A2 (en) *	2005-04-20	2006-10-26	University Of Florida Research Foundation, Inc.	Bone marrow-derived neurogenic cells and uses thereof
AU2006241123B2 (en) *	2005-04-25	2013-10-03	Massachusetts Institute Of Technology	Compositions and methods for promoting hemostasis and other physiological activities
AU2006202209B2 (en) *	2005-05-27	2011-04-14	Lifescan, Inc.	Amniotic fluid derived cells
ES2400916T3 (es) *	2005-06-08	2013-04-15	Janssen Biotech, Inc.	Una terapia celular para degeneración ocular
GB0511723D0 (en) *	2005-06-09	2005-07-13	Smith & Nephew	Placental stem cells
WO2006135899A2 (en) *	2005-06-13	2006-12-21	The Johns Hopkins University	Survival, differentiation and structural intergration of human neural stem cells grafted into the adult spinal cord
RU2284190C1 (ru) *	2005-06-14	2006-09-27	Дмитрий Дмитриевич Генкин	Способ лечения ишемической болезни сердца, или инфаркта миокарда и его последствий, или ишемии мозга, вызванной атеросклерозом или острым нарушением мозгового кровообращения, и ее последствий, или ишемии нижних конечностей, вызванной атеросклерозом
US7838503B2 (en) *	2005-06-15	2010-11-23	Children's Medical Center Corporation	Methods for extending the replicative lifespan of cells
US20150119794A1 (en) *	2005-08-05	2015-04-30	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
US20140336514A1 (en) *	2005-08-05	2014-11-13	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
EP2324838A1 (en)	2005-09-12	2011-05-25	Abela Pharmaceuticals, Inc.	Compositions Comprising Dimethyl Sulfoxide (DMSO)
AU2006291134C1 (en)	2005-09-12	2013-08-15	Abela Pharmaceuticals, Inc.	Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
WO2007033180A1 (en)	2005-09-12	2007-03-22	Abela Pharmaceuticals, Inc.	Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US8480797B2 (en)	2005-09-12	2013-07-09	Abela Pharmaceuticals, Inc.	Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
JP2007106760A (ja) *	2005-09-16	2007-04-26	Kenji Yoshida	造血幹細胞増殖剤
DK1926813T4 (da)	2005-09-23	2019-08-19	Tigenix S A U	Cellepopulationer med immunregulatorisk aktivitet, fremgangsmåde til isolering og anvendelser
WO2007038686A2 (en)	2005-09-27	2007-04-05	Tissuetech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
CA2856662C (en)	2005-10-13	2017-09-05	Anthrogenesis Corporation	Immunomodulation using placental stem cells
US8071376B2 (en) *	2005-10-13	2011-12-06	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
JP4921767B2 (ja) *	2005-10-14	2012-04-25	株式会社カネカ	細胞の分化誘導方法
US10117900B2 (en) *	2005-11-09	2018-11-06	Athersys, Inc.	MAPC treatment of brain injuries and diseases
WO2007056560A2 (en) *	2005-11-09	2007-05-18	Chemimage Corporation	System and method for cytological analysis by raman spectroscopic imaging
US11000546B2 (en)	2005-11-09	2021-05-11	Athersys, Inc.	Immunomodulatory properties of MAPCs and uses thereof
US20090170059A1 (en) *	2005-11-14	2009-07-02	Hans Klingemann	Methods for Preparing Cord Matrix Stem Cells (CMSC) for Long Term Storage and for Preparing a Segment of umbilical cord for cryopreservation
JP5368102B2 (ja) *	2005-11-17	2013-12-18	バイオミメティックセラピューティクス，インコーポレイテッド	ｒｈＰＤＧＦ−ＢＢ及び生体適合性マトリックスを用いた顎顔面骨強化
PL1971681T3 (pl) *	2005-12-16	2018-01-31	Depuy Synthes Products Inc	Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej
ES2391034T3 (es) *	2005-12-19	2012-11-20	Ethicon, Inc.	Expansión in vitro de células derivadas postparto en frascos rotatorios
US8278102B2 (en)	2005-12-22	2012-10-02	Jane Ennis	Viable cells from frozen umbilical cord tissue
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
WO2007076522A2 (en) *	2005-12-28	2007-07-05	Ethicon, Incorporated	Treatment of peripheral vascular disease using postpartum-derived cells
CN105106239A (zh) *	2005-12-28	2015-12-02	伊西康公司	使用产后衍生细胞治疗外周血管疾病
JP2009521930A (ja)	2005-12-29	2009-06-11	アントフロゲネシスコーポレーション	胎盤幹細胞及び第２供給源由来幹細胞の共存培養
KR20200123283A (ko)	2005-12-29	2020-10-28	안트로제네시스 코포레이션	태반 줄기 세포 집단
CN101374941A (zh) *	2005-12-29	2009-02-25	人类起源公司	采集和保存胎盘干细胞的改良组合物及其使用方法
WO2007080591A2 (en)	2006-01-11	2007-07-19	Technion Research & Development Foundation Ltd.	Adult stem cell-derived connective tissue progenitors for tissue engineering
US20080286249A1 (en) *	2006-01-12	2008-11-20	Varney Timothy R	Use of mesenchymal stem cells for treating genetic diseases and disorders
US20070253931A1 (en) *	2006-01-12	2007-11-01	Osiris Therapeutics, Inc.	Use of mesenchymal stem cells for treating genetic diseases and disorders
US8871198B2 (en) *	2006-03-29	2014-10-28	Stemnion, Inc.	Methods related to wound healing
US9944900B2 (en) *	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
GB0600972D0 (en) *	2006-01-18	2006-03-01	Univ Leeds	Enrichment of cells
US7875451B2 (en) *	2006-01-19	2011-01-25	The University Of Washington	Formulation to improve survival of transplanted cells
CA2642887C (en)	2006-01-23	2021-08-03	Athersys, Inc.	Mapc therapeutics without adjunctive immunosuppressive treatment
WO2007087519A2 (en) *	2006-01-24	2007-08-02	Centeno Christopher J	Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
FR2896511B1 (fr) *	2006-01-26	2012-10-26	Centre Nat Rech Scient	Procede de culture de cellules issues du tissu adipeux et leurs applications.
AU2007212273B2 (en) *	2006-02-09	2013-10-10	Stryker Corporation	Compositions and methods for treating bone
WO2007099337A1 (en) *	2006-03-01	2007-09-07	Cartela R&D Ab	Expansion and differentiation of mesenchymal stem cells
US20090280093A1 (en) *	2006-03-01	2009-11-12	The Regenerative Medicine Institute	Compositions and populations of cells obtained from the umbilical cord and methods of producing the same
US20110171182A1 (en) *	2006-03-23	2011-07-14	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
BRPI0709349A2 (pt) *	2006-03-23	2011-07-12	Pluristem Ltd	métodos para expansão celular e usos de células e de meios condicionados produzidos através deles para terapia
CA2646491A1 (en) *	2006-04-17	2007-10-25	Bioe, Inc.	Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US20090208466A1 (en) *	2006-04-21	2009-08-20	James Yoo	Ink-jet printing of tissues
US9456979B2 (en) *	2006-04-27	2016-10-04	Sri International	Adminstration of intact mammalian cells to the brain by the intranasal route
US8741643B2 (en)	2006-04-28	2014-06-03	Lifescan, Inc.	Differentiation of pluripotent stem cells to definitive endoderm lineage
CA2871219C (en)	2006-05-05	2020-06-30	John E. Davies	Immune privileged and modulatory progenitor cells
KR101514078B1 (ko) *	2006-05-11	2015-04-22	나오코 다케베	제대혈(臍帶血) 줄기 세포 수집 및 그 사용 방법
US20080050814A1 (en) *	2006-06-05	2008-02-28	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
US20080064098A1 (en) *	2006-06-05	2008-03-13	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of maternal placental cells
CN101501185A (zh) *	2006-06-09	2009-08-05	人类起源公司	胎盘巢(placental niche)及其培养干细胞的用途
WO2007145889A1 (en) *	2006-06-14	2007-12-21	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
US8475788B2 (en)	2006-06-14	2013-07-02	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
US20070292401A1 (en) *	2006-06-20	2007-12-20	Harmon Alexander M	Soft tissue repair and regeneration using stem cell products
TW200810769A (en) *	2006-06-28	2008-03-01	Univ Kansas	Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
US9642891B2 (en) *	2006-06-30	2017-05-09	Biomimetic Therapeutics, Llc	Compositions and methods for treating rotator cuff injuries
US9161967B2 (en)	2006-06-30	2015-10-20	Biomimetic Therapeutics, Llc	Compositions and methods for treating the vertebral column
WO2008013557A1 (en)	2006-07-24	2008-01-31	International Stem Cell Corporation	Synthetic cornea from retinal stem cells
US7993918B2 (en) *	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US7736485B2 (en) *	2006-08-11	2010-06-15	Aqua Resources Corporation	Nanoplatelet magnesium hydroxides and methods of preparing same
US8822030B2 (en)	2006-08-11	2014-09-02	Aqua Resources Corporation	Nanoplatelet metal hydroxides and methods of preparing same
US7671014B2 (en) *	2006-08-14	2010-03-02	Warsaw Orthopedic, Inc.	Flowable carrier matrix and methods for delivering to a patient
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
JP5656183B2 (ja) *	2006-08-22	2015-01-21	国立大学法人東京医科歯科大学	滑膜由来間葉幹細胞（ＭＳＣｓ）の軟骨・半月板再生への応用
US20080082170A1 (en) *	2006-09-29	2008-04-03	Peterman Marc M	Apparatus and methods for surgical repair
US20080078412A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant
US20080078411A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant for sleep apnea
AU2007308168B2 (en)	2006-10-12	2013-09-26	Ethicon, Inc.	Kidney-derived cells and methods of use in tissue repair and regeneration
EP1913869A3 (en) *	2006-10-19	2008-12-10	Esaote S.p.A.	Diagnostic imaging method and apparatus for the anatomical region of the pelvic floor
EP2420567A3 (en) *	2006-10-23	2015-09-30	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
AU2007333425B2 (en) *	2006-11-03	2014-03-27	Stryker Corporation	Compositions and methods for arthrodetic procedures
WO2008060541A2 (en)	2006-11-13	2008-05-22	Ethicon, Incorporated	In vitro expansion of postpartum-derived cells using microcarriers
US20080132803A1 (en) *	2006-11-30	2008-06-05	Hyman Friedlander	Method and system for doing business by mining the placental-chord complex
US20080152630A1 (en) *	2006-12-07	2008-06-26	Irene Ginis	Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
WO2008082525A1 (en) *	2006-12-19	2008-07-10	National Stem Cell Inc	Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
US20100303770A1 (en) *	2006-12-28	2010-12-02	John Maslowski	Methods for culturing dermal cells for treatment of skin injuries such as burns
US7980000B2 (en)	2006-12-29	2011-07-19	Applied Materials, Inc.	Vapor dryer having hydrophilic end effector
US8506949B2 (en)	2007-01-17	2013-08-13	Stemnion, Inc.	Methods for modulating inflammatory and/or immune responses
WO2008088738A2 (en)	2007-01-17	2008-07-24	Stemnion, Inc.	Novel methods for modulating inflammatory and/or immune responses
PT2120977E (pt)	2007-02-12	2013-09-16	Anthrogenesis Corp	Tratamento de doenças inflamatórias utilizando células estaminais da placenta
JP2010518812A (ja)	2007-02-12	2010-06-03	アンスロジェネシスコーポレーション	接着性胎盤幹細胞由来の肝細胞および軟骨細胞、ならびにｃｄ３４＋、ｃｄ４５−胎盤幹細胞の濃縮細胞集団
US20100151025A1 (en) *	2007-02-20	2010-06-17	Biomimetic Therapeutics, Inc.	Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
EP2132299A4 (en) *	2007-03-01	2010-03-10	Cryo Cell Int	OBTAINING, ISOLATING, AND CRYOKON SUSPENSION OF ENDOMETRY / MENSTRUATION CELLS
WO2008109816A1 (en) *	2007-03-08	2008-09-12	Hemacell Perfusion, Inc.	Method for isolation of afterbirth derived cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
CA2683056C (en) *	2007-04-07	2020-03-24	Whitehead Institute For Biomedical Research	Reprogramming of somatic cells
WO2009008928A2 (en) *	2007-04-13	2009-01-15	Stemnion, Inc.	Methods for treating nervous system injury and disease
WO2008132722A1 (en)	2007-04-26	2008-11-06	Ramot At Tel-Aviv University Ltd.	Pluripotent autologous stem cells from oral mucosa and methods of use
WO2008137115A1 (en)	2007-05-03	2008-11-13	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8574567B2 (en)	2007-05-03	2013-11-05	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8114668B2 (en) *	2007-05-14	2012-02-14	Cardiac Pacemakers, Inc.	Composition for cold storage of stem cells
US20100111914A1 (en) *	2007-05-21	2010-05-06	Yuanyuan Zhang	Stem cells from urine and methods for using the same
KR101722033B1 (ko)	2007-05-21	2017-03-31	웨이크 포리스트 유니버시티 헬스 사이언시즈	소변으로부터의 전구 세포 및 이를 사용하는 방법
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
WO2008148105A1 (en) *	2007-05-25	2008-12-04	Medistem Laboratories, Inc.	Endometrial stem cells and methods of making and using same
ATE487441T1 (de) *	2007-06-01	2010-11-15	Allergan Inc	Gerät zur erzeugung des zugspannungsinduzierten wachstums von biologischem gewebe
US9693486B1 (en) *	2007-06-14	2017-06-27	Switch, Ltd.	Air handling unit with a canopy thereover for use with a data center and method of using the same
EP2164953A4 (en)	2007-06-18	2010-06-30	Childrens Hosp & Res Ct Oak	METHOD OF ISOLATING STAIN AND PRECIPITATING CELLS FROM PLAZENTA
US20090004253A1 (en) *	2007-06-29	2009-01-01	Brown Laura J	Composite device for the repair or regeneration of tissue
US20090004271A1 (en) *	2007-06-29	2009-01-01	Brown Laura J	Morselized foam for wound treatment
US9080145B2 (en)	2007-07-01	2015-07-14	Lifescan Corporation	Single pluripotent stem cell culture
US9095562B2 (en)	2007-07-05	2015-08-04	Regenerative Sciences, Inc.	Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
DE102007034679A1 (de)	2007-07-25	2009-01-29	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Materialzusammensetzungen, welche aus exokrinem Drüsengewebe erhaltene adulte Stammzellen enthalten, insbesondere zur Verwendung in der Regenerationsmedizin, z.B. zur Wiederherstellung von verletztem oder geschädigtem Myokardgewebe
US20090024224A1 (en)	2007-07-16	2009-01-22	Chen Silvia S	Implantation of cartilage
US20090029463A1 (en) *	2007-07-25	2009-01-29	Bioe, Inc.	Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
EP2182971B1 (en)	2007-07-27	2013-12-18	Humacyte, Inc.	Compositions comprising human collagen and human elastin and uses thereof
EP2610336A1 (en)	2007-07-31	2013-07-03	Lifescan, Inc.	Differentiation of human embryonic stem cells
AU2008284277B2 (en) *	2007-08-08	2011-04-28	Shire Regenerative Medicine, Inc.	Materials and methods for treating skeletal system damage and promoting skeletal system repair and regeneration
US20090062907A1 (en) *	2007-08-31	2009-03-05	Quijano Rodolfo C	Self-expanding valve for the venous system
US20090068153A1 (en) *	2007-09-06	2009-03-12	Vitelli Francesca P	Cell composition for tissue regeneration
EP2197270B8 (en)	2007-09-07	2020-03-04	Surgical Biologics, LLC	Placental tissue grafts and improved methods of preparing and using the same
KR20100075924A (ko) *	2007-09-19	2010-07-05	플루리스템 리미티드	지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
WO2009042768A1 (en) *	2007-09-25	2009-04-02	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Triggerably dissolvable hollow fibers for controlled delivery
KR20220122774A (ko) *	2007-09-26	2022-09-02	셀룰래리티 인코포레이티드	인간 태반 관류액으로부터의 혈관형성 세포
RS53841B1 (sr) *	2007-09-28	2015-06-30	Anthrogenesis Corporation	Supresija tumora korišćenjem humanog placentalnog perfuzata i intermedijernih ćelija ubica poreklom iz humane placente
US8034329B2 (en) *	2007-10-05	2011-10-11	Advanced Technologies And Regenerative Medicine, Llc	Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
WO2009052209A2 (en) *	2007-10-16	2009-04-23	University Of Kansas	Isolation of stem cells and effective control of contamination
US20120219737A1 (en)	2007-10-19	2012-08-30	University Of Medicine And Dentistry Of New Jersey	Production of extracellular matrix, conditioned media and uses thereof
WO2009052459A1 (en) *	2007-10-19	2009-04-23	University Of Medicine And Dentistry Of New Jersey	A method of using an extracellular matrix to enhance cell transplant survival and differentiation
KR20160040739A (ko) *	2007-11-07	2016-04-14	안트로제네시스 코포레이션	조산 합병증의 치료에 있어서의 제대혈의 용도
US20110086080A1 (en) *	2007-11-14	2011-04-14	Osteosphere, Llc	Ex-vivo production of human demineralized bone matrix
MX2010005805A (es)	2007-11-27	2010-06-09	Lifescan Inc	Diferenciacion de celulas madre embrionarias humanas.
US20090163990A1 (en) *	2007-12-19	2009-06-25	Chunlin Yang	Decellularized omentum matrix and uses thereof
WO2009085969A2 (en)	2007-12-19	2009-07-09	Regenerative Sciences, Llc	Compositions and methods to promote implantation and engrafment of stem cells
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
WO2009085216A2 (en)	2007-12-20	2009-07-09	Squicor	Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
BRPI0821489A2 (pt) *	2007-12-27	2015-06-16	Ethicon Inc	Tratamento de degeneração do disco intervetebral com o uso de células derivadas de tecido de cordão umbilical humano
US20100279413A1 (en) *	2008-01-14	2010-11-04	Zymes, Llc	Applications of ubiquinones and ubiquinols
US8088163B1 (en)	2008-02-06	2012-01-03	Kleiner Jeffrey B	Tools and methods for spinal fusion
EP3095470A1 (en) *	2008-02-07	2016-11-23	Shahar Cohen	Compartmental extract compositions for tissue engineering
JP5864106B2 (ja)	2008-02-07	2016-02-17	バイオミメティックセラピューティクス，エルエルシー	仮骨延長のための組成物および方法
US20090209456A1 (en) *	2008-02-19	2009-08-20	Iliana Sweis	Compositions and methods for improving facial and body aesthetics
MX2010009251A (es)	2008-02-21	2010-11-25	Centocor Ortho Biotech Inc	Metodos, placas de superficie modificada y composiciones para la fijacion, el cultivo y el desprendimiento celular.
US8318485B2 (en) *	2008-02-25	2012-11-27	Natalie Gavrilova	Stem cell therapy for the treatment of diabetic retinopathy and diabetic optic neuropathy
US20090220995A1 (en)	2008-02-28	2009-09-03	Sachs David H	Multiple administrations of umbilicus derived cells
US20090232782A1 (en) *	2008-03-14	2009-09-17	Yu-Show Fu	Method for treating brain ischemic injury through transplantation of human umbilical mesenchymal stem cells
EP2257176B1 (en)	2008-03-14	2013-09-18	Regenerative Sciences, LLC	Compositions and methods for cartilage repair
US9005599B2 (en)	2008-04-21	2015-04-14	Tissue Regeneration Therapeutics Inc.	Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US8623648B2 (en)	2008-04-24	2014-01-07	Janssen Biotech, Inc.	Treatment of pluripotent cells
US9480549B2 (en)	2008-04-25	2016-11-01	Allosource	Multi-layer tissue patches
US9358320B2 (en)	2008-04-25	2016-06-07	Allosource	Multi-layer tissue patches
JP2011519616A (ja) *	2008-04-30	2011-07-14	エシコン・インコーポレイテッド	組織工学による血管
US20110143429A1 (en) *	2008-04-30	2011-06-16	Iksoo Chun	Tissue engineered blood vessels
EP2294187A2 (en) *	2008-05-21	2011-03-16	BioE LLC	Differentiation of multi-lineage progenitor cells to pancreatic cells
US20210378834A1 (en)	2008-05-22	2021-12-09	Spinal Surgical Strategies, Inc., A Nevada Corporation D/B/A Kleiner Device Labs	Spinal fusion cage system with inserter
US8748181B2 (en) *	2008-05-23	2014-06-10	President And Fellows Of Harvard College	Methods of generating patterned soft substrates and uses thereof
US20090297485A1 (en) *	2008-05-28	2009-12-03	Allan Mishra	Compositions and methods for treating psychiatric and neurodegenerative disorders
WO2009152384A1 (en) *	2008-06-11	2009-12-17	The Children's Mercy Hospital	Solutions for tissue engineering and methods of use
CA3060170A1 (en)	2008-06-13	2009-12-17	Whitehead Institute For Biomedical Research	Programming and reprogramming of cells
WO2009158480A2 (en) *	2008-06-26	2009-12-30	Kci Licensing, Inc.	Stimulation of cartilage formation using reduced pressure treatment
JP5294041B2 (ja) *	2008-06-27	2013-09-18	独立行政法人産業技術総合研究所	膵臓疾患又は糖尿病のための膵臓細胞再生移植用キット
AU2009267167A1 (en) *	2008-06-30	2010-01-07	Centocor Ortho Biotech Inc.	Differentiation of pluripotent stem cells
ES2697798T3 (es)	2008-06-30	2019-01-28	Janssen Biotech Inc	Diferenciación de células madre pluripotentes
US20100028307A1 (en) *	2008-07-31	2010-02-04	O'neil John J	Pluripotent stem cell differentiation
KR20220025141A (ko) *	2008-08-20	2022-03-03	셀룰래리티 인코포레이티드	개선된 세포 조성물 및 그의 제조 방법
KR20210149904A (ko) *	2008-08-20	2021-12-09	안트로제네시스 코포레이션	단리된 태반 세포를 사용한 뇌졸중 치료
AU2009283161A1 (en)	2008-08-22	2010-02-25	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
RU2539786C2 (ru)	2008-09-02	2015-01-27	Плуристем Лтд.	Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
NZ602861A (en)	2008-09-09	2014-03-28	Biomimetic Therapeutics Llc	Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
US20100069827A1 (en) *	2008-09-12	2010-03-18	Barry Neil Silberg	Pre-Surgical Prophylactic Administration of Antibiotics and Therapeutic Agents
US9446227B2 (en)	2008-09-12	2016-09-20	Sonescence, Inc.	Ultrasonic dispersion of compositions in tissue
ES2624484T3 (es)	2008-10-06	2017-07-14	3-D Matrix, Ltd.	Tapón de tejido
US20110300203A1 (en) *	2008-10-22	2011-12-08	Trustees Of Columbia University In The City Of New York	Cartilage regeneration without cell transplantation
RU2522001C2 (ru)	2008-10-31	2014-07-10	Сентокор Орто Байотек Инк.	Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток
KR102025158B1 (ko) *	2008-10-31	2019-09-25	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 췌장 내분비 계통으로의 분화
KR20160132133A (ko)	2008-10-31	2016-11-16	신세스 게엠바하	줄기 세포를 활성화시키는 방법 및 장치
BRPI0921494A2 (pt)	2008-11-03	2018-10-30	Prad Reasearch And Development Ltd	método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
NZ592726A (en)	2008-11-19	2012-12-21	Anthrogenesis Corp	Amnion derived adherent cells
CA2744227C (en)	2008-11-20	2018-10-02	Centocor Ortho Biotech Inc.	Methods and compositions for cell attachment and cultivation on planar substrates
JP2012509085A (ja)	2008-11-20	2012-04-19	ヤンセンバイオテツク，インコーポレーテツド	マイクロキャリア上での多能性幹細胞の培養
US8323352B2 (en) *	2008-11-20	2012-12-04	Lifecell Corporation	Method for treatment and prevention of parastomal hernias
US20100143312A1 (en) *	2008-11-21	2010-06-10	Hariri Robert J	Treatment of diseases, disorders or conditions of the lung using placental cells
US8366748B2 (en)	2008-12-05	2013-02-05	Kleiner Jeffrey	Apparatus and method of spinal implant and fusion
CN102325536A (zh)	2008-12-05	2012-01-18	再生科学有限责任公司	促进无血管组织修复的方法和组合物
JPWO2010064702A1 (ja) *	2008-12-05	2012-05-10	国立大学法人東京大学	癌の予後を予測するためのバイオマーカー
US20100168022A1 (en) *	2008-12-11	2010-07-01	Centeno Christopher J	Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
PL2379088T3 (pl) *	2008-12-19	2018-07-31	DePuy Synthes Products, Inc.	Leczenie płuca oraz chorób i zaburzeń płucnych
CA2747758C (en) *	2008-12-19	2020-09-22	Ethicon, Incorporated	Regeneration and repair of neural tissue following injury
PT2379087E (pt) *	2008-12-19	2014-12-02	Depuy Synthes Products Llc	Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
US20130302283A1 (en) *	2012-05-14	2013-11-14	Advanced Technologies And Regenerative Medicine, Llc	hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
US10179900B2 (en) *	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
US8771677B2 (en) *	2008-12-29	2014-07-08	Vladimir B Serikov	Colony-forming unit cell of human chorion and method to obtain and use thereof
EP2370009B1 (en) *	2008-12-30	2017-08-02	KCI Licensing, Inc.	Reduced pressure augmentation of microfracture for cartilage repair
KR101632756B1 (ko) *	2009-01-23	2016-06-22	고쿠리츠다이가쿠호우진 도쿄다이가쿠	배양 세포의 평가 방법
US9247943B1 (en)	2009-02-06	2016-02-02	Kleiner Intellectual Property, Llc	Devices and methods for preparing an intervertebral workspace
US20120142603A1 (en) *	2009-02-12	2012-06-07	University Of Southern California	Bioadhesive patch for sutureless closure of soft tissue
KR101422690B1 (ko) *	2009-02-27	2014-07-23	(주)차바이오앤디오스텍	배아줄기세포 유래 혈관형성전구세포의 배양 분비물을 포함하는 피부재생용 조성물 및 이의 용도
BRPI1013409A2 (pt) *	2009-03-26	2018-01-16	Advanced Tech And Regenerative Medicine Llc	células de tecido de cordão umbilical humano como terapia para doença de alzheimer
CN102439136A (zh) *	2009-03-26	2012-05-02	加州大学校董	产生用于疾病修饰的抑制性rna的间充质干细胞
WO2010118059A1 (en) *	2009-04-06	2010-10-14	Capricor, Inc.	Systems and methods for cardiac tissue repair
WO2010131917A2 (ko) *	2009-05-13	2010-11-18	메디포스트(주)	줄기세포의 세포 활성과 연관된 ｔｓｐ-1, ｔｓｐ-2, ｉｌ-17ｂｒ 및 ｈｂ-ｅｇｆ 및 이들의 용도
US20110020271A1 (en) *	2009-05-20	2011-01-27	Humacyte, Inc.	Elastin for soft tissue augmentation
EP2434896A4 (en) *	2009-05-28	2014-01-22	Univ Central Florida Res Found	IN VITRO PRODUCTION OF OLIGODIAN DROCYTES FROM HEMAN NAIL CORD STEM CELLS
US20150335400A1 (en) *	2009-06-17	2015-11-26	The Trustees Of Columbia University In The City Of New York	Tooth scaffolds
KR101893021B1 (ko) *	2009-07-20	2018-08-29	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 분화
EP2456862A4 (en)	2009-07-20	2013-02-27	Janssen Biotech Inc	DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
GB2485113B (en)	2009-07-20	2016-12-28	Janssen Biotech Inc	Differentiation of human embryonic stem cells into cells of the pancreatic endoderm lineage
CA2768576C (en) *	2009-07-21	2022-12-06	Abt Holding Company	Use of stem cells to reduce leukocyte extravasation
ES2360434B1 (es)	2009-07-21	2012-04-12	Universitat Internacional De Catalunya	Celulas madre pluripotenciales obtenidas a partir de la pulpa dental.
WO2011022070A2 (en) *	2009-08-20	2011-02-24	The Regents Of The University Of California	Perivascular stem cell composition for bone
US20110054929A1 (en) *	2009-09-01	2011-03-03	Cell Solutions Colorado Llc	Stem Cell Marketplace
US8207651B2 (en)	2009-09-16	2012-06-26	Tyco Healthcare Group Lp	Low energy or minimum disturbance method for measuring frequency response functions of ultrasonic surgical devices in determining optimum operating point
US10973656B2 (en)	2009-09-18	2021-04-13	Spinal Surgical Strategies, Inc.	Bone graft delivery system and method for using same
US9173694B2 (en)	2009-09-18	2015-11-03	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US8685031B2 (en)	2009-09-18	2014-04-01	Spinal Surgical Strategies, Llc	Bone graft delivery system
US20170238984A1 (en)	2009-09-18	2017-08-24	Spinal Surgical Strategies, Llc	Bone graft delivery device with positioning handle
US10245159B1 (en)	2009-09-18	2019-04-02	Spinal Surgical Strategies, Llc	Bone graft delivery system and method for using same
US9186193B2 (en)	2009-09-18	2015-11-17	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US8906028B2 (en)	2009-09-18	2014-12-09	Spinal Surgical Strategies, Llc	Bone graft delivery device and method of using the same
USD723682S1 (en)	2013-05-03	2015-03-03	Spinal Surgical Strategies, Llc	Bone graft delivery tool
US9060877B2 (en)	2009-09-18	2015-06-23	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US9629729B2 (en)	2009-09-18	2017-04-25	Spinal Surgical Strategies, Llc	Biological delivery system with adaptable fusion cage interface
USD750249S1 (en)	2014-10-20	2016-02-23	Spinal Surgical Strategies, Llc	Expandable fusion cage
CA3049393C (en) *	2009-09-23	2020-12-29	Restem Llc	Umbilical cord lining stem cells and methods and material for isolating and culturing same
ES2609006T3 (es)	2009-10-16	2017-04-18	Rutgers, The State University Of New Jersey	Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
CA2778817A1 (en) *	2009-10-29	2011-05-19	Janssen Biotech, Inc.	Pluripotent stem cells
WO2011053875A1 (en)	2009-10-30	2011-05-05	Tandem Abela Development Group Llc	Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases
US9113950B2 (en)	2009-11-04	2015-08-25	Regenerative Sciences, Llc	Therapeutic delivery device
US20130028978A1 (en) *	2009-11-10	2013-01-31	The Trustees Of Columbia University In The City Of New York	Compositions and methods for wound treatment
US20130129686A1 (en) *	2009-11-19	2013-05-23	Regents Of The University	Reducing Inflammation Using Cell Therapy
KR101841271B1 (ko)	2009-12-23	2018-03-22	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 분화
DK2516625T3 (da) *	2009-12-23	2024-09-09	Janssen Biotech Inc	Differentiering af humane embryonale stamceller
EP2529007B1 (en) *	2010-01-26	2017-07-12	Anthrogenesis Corporation	Treatment of bone-related cancers using placental stem cells
CN102781455B (zh)	2010-01-26	2014-06-04	干细胞旋转股份公司	来自来源于正在生长的鹿茸的干细胞的细胞匀浆物、获得其的方法及其用途
EP3351624B1 (en)	2010-02-18	2022-09-14	Osiris Therapeutics, Inc.	Methods of manufacture of therapeutic products comprising vitalized placental dispersions
ES2705684T3 (es) *	2010-02-19	2019-03-26	Lifecell Corp	Dispositivos de tratamiento de la pared abdominal
US8492335B2 (en)	2010-02-22	2013-07-23	Biomimetic Therapeutics, Llc	Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
AU2011223900A1 (en) *	2010-03-01	2012-09-13	Janssen Biotech, Inc.	Methods for purifying cells derived from pluripotent stem cells
AU2011237747B2 (en)	2010-04-07	2015-07-23	Celularity Inc.	Angiogenesis using placental stem cells
US8562973B2 (en)	2010-04-08	2013-10-22	Anthrogenesis Corporation	Treatment of sarcoidosis using placental stem cells
US9845457B2 (en)	2010-04-30	2017-12-19	Cedars-Sinai Medical Center	Maintenance of genomic stability in cultured stem cells
US8529883B2 (en)	2010-05-07	2013-09-10	Fibrocell Technologies, Inc.	Dosage unit formulations of autologous dermal fibroblasts
WO2011143299A2 (en)	2010-05-12	2011-11-17	Centocor Ortho Biotech Inc.	Differentiation of human embryonic stem cells
US9352003B1 (en)	2010-05-14	2016-05-31	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en)	2010-05-14	2018-11-20	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en)	2010-05-14	2014-11-11	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US20130209415A1 (en) *	2010-06-03	2013-08-15	The Board Of Trustees Of The Leland Stanford Junior University	Purified compositions of cardiovascular progenitor cells
HUE032727T2 (en)	2010-07-02	2017-10-30	Marsha Lynn Roach	Biometric skeletons for industrial scale dispersion
JP5876045B2 (ja)	2010-07-12	2016-03-02	ユニバーシティーオブサザンカリフォルニア	幹細胞と標的組織の相互接続を促進する生体適合性基材およびそれを埋め込む方法
US8825388B2 (en)	2010-07-13	2014-09-02	Qualcomm Incorporated	Indoor likelihood heatmap
CN103097520B (zh)	2010-07-13	2017-12-05	人类起源公司	产生自然杀伤细胞的方法
US20130203146A1 (en) *	2010-08-03	2013-08-08	Jackie Y. Ying	Microfabricated scaffold structures
JP2012031127A (ja) *	2010-08-03	2012-02-16	Nagoya Univ	臍帯由来間葉系幹細胞を含む組成物
IL207586A0 (en)	2010-08-12	2010-12-30	Omrix Biopharmaceuticals Ltd	A fibrin based therapeutic preparation and use thereof
WO2012021885A1 (en) *	2010-08-13	2012-02-16	The Trustees Of Columbia University In The City Of New York	Three-dimensional tissue engineering devices and uses thereof
US9181528B2 (en)	2010-08-31	2015-11-10	Janssen Biotech, Inc.	Differentiation of pluripotent stem cells
EP2611906B1 (en) *	2010-08-31	2024-01-03	Gallant Pet, Inc.	Systemic, allogenic stem cell therapies for treatment of diseases in cats and dogs
SG187946A1 (en)	2010-08-31	2013-03-28	Janssen Biotech Inc	Differentiation of human embryonic stem cells
ES2659393T3 (es)	2010-08-31	2018-03-15	Janssen Biotech, Inc.	Diferenciación de células madre embrionarias humanas
EP2625264B1 (en)	2010-10-08	2022-12-07	Terumo BCT, Inc.	Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US8546338B2 (en)	2010-12-08	2013-10-01	Johnson & Johnson Consumer Companies, Inc.	Self-assembling hydrogels based on dicephalic peptide amphiphiles
US8574899B2 (en)	2010-12-22	2013-11-05	Vladimir B Serikov	Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
AR093183A1 (es)	2010-12-31	2015-05-27	Anthrogenesis Corp	Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
JP5388233B2 (ja) *	2011-01-19	2014-01-15	富士ソフト株式会社	再生軟骨の軟骨特性を評価する方法
US12093036B2 (en)	2011-01-21	2024-09-17	Teladoc Health, Inc.	Telerobotic system with a dual application screen presentation
US8945536B2 (en) *	2011-01-26	2015-02-03	The Chinese University Of Hong Kong	Stem cell sheet for tissue repair
ES2939147T3 (es)	2011-03-18	2023-04-19	Microvascular Tissues Inc	Tejido microvascular alogénico para tratamientos de tejidos blandos
WO2012127320A1 (en)	2011-03-22	2012-09-27	Pluristem Ltd.	Methods for treating radiation or chemical injury
US9526770B2 (en)	2011-04-28	2016-12-27	Tissuetech, Inc.	Methods of modulating bone remodeling
CA2834496A1 (en)	2011-04-28	2012-11-01	Aquero Company, Llc	Lysine-based polymer coagulants for use in clarification of process waters
WO2012149468A2 (en)	2011-04-29	2012-11-01	University Of Southern California	Instruments and methods for the implantation of cell-seeded substrates
US8877489B2 (en)	2011-12-05	2014-11-04	California Institute Of Technology	Ultrathin parylene-C semipermeable membranes for biomedical applications
US8834928B1 (en)	2011-05-16	2014-09-16	Musculoskeletal Transplant Foundation	Tissue-derived tissugenic implants, and methods of fabricating and using same
ES2874487T3 (es) *	2011-05-31	2021-11-05	Lifecell Corp	Matrices de tejido adiposo
PL2714059T3 (pl)	2011-06-01	2019-04-30	Celularity Inc	Leczenie bólu z użyciem komórek macierzystych łożyska
US9682044B2 (en)	2011-06-10	2017-06-20	Tissuetech, Inc.	Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
WO2012177927A1 (en)	2011-06-21	2012-12-27	Mayo Foundation For Medical Education And Research	Transgenic animals capable of being induced to delete senescent cells
JP6243839B2 (ja)	2011-06-29	2017-12-06	バイオリストーラティブセラピーズ，インコーポレイテッド	褐色脂肪細胞の組成物および方法
US20130005829A1 (en)	2011-06-30	2013-01-03	Advanced Technologies And Regenerative Medicine, Llc.	Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom
WO2013010045A1 (en)	2011-07-12	2013-01-17	Biotime Inc.	Novel methods and formulations for orthopedic cell therapy
AU2011374879C1 (en)	2011-08-10	2018-06-14	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9925221B2 (en)	2011-09-09	2018-03-27	Celularity, Inc.	Treatment of amyotrophic lateral sclerosis using placental stem cells
US9248013B2 (en)	2011-12-05	2016-02-02	California Institute Of Technology	3-Dimensional parylene scaffold cage
US20140335074A1 (en)	2011-12-13	2014-11-13	Buck Institute For Research On Aging	Methods for improving medical therapies
US9162011B2 (en)	2011-12-19	2015-10-20	Allosource	Flowable matrix compositions and methods
US20130157365A1 (en) *	2011-12-20	2013-06-20	Advanced Technologies And Regenerative Medicine, Llc	Induced pluripotent stem cells from human umbilical cord tissue-derived cells
EP3501558B1 (en)	2011-12-20	2020-11-25	LifeCell Corporation	Flowable tissue products
US9532863B2 (en)	2011-12-20	2017-01-03	Lifecell Corporation	Sheet tissue products
KR102090751B1 (ko)	2011-12-22	2020-03-19	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
MX362198B (es)	2011-12-23	2019-01-08	Depuy Synthes Products Llc	Deteccion de celulas derivadas de tejido de cordon umbilical humano.
US9803176B2 (en)	2011-12-30	2017-10-31	Amit Patel	Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses
WO2013112350A1 (en)	2012-01-24	2013-08-01	Lifecell Corporation	Elongated tissue matrices
WO2013126674A1 (en) *	2012-02-23	2013-08-29	Anthrogenesis Corporation	Identification of antitumor compounds using placenta
US8940294B2 (en)	2012-03-02	2015-01-27	Tissuetech, Inc.	Methods of isolating and culturing stem cells
EP2823037A4 (en)	2012-03-07	2015-09-16	Janssen Biotech Inc	DEFINED MEDIA FOR THE EXPANSION AND CARE OF PLURIPOTENTAL STEM CELLS
US20150064137A1 (en)	2012-04-17	2015-03-05	Kythera Biopharmaceuticals, Inc.	Use of engineered viruses to specifically kill senescent cells
US9999637B2 (en)	2012-04-24	2018-06-19	Lifecell Corporation	Functionalized tissue matrices
WO2013184527A1 (en)	2012-06-05	2013-12-12	Capricor, Inc.	Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
CN108034633B (zh)	2012-06-08	2022-08-02	詹森生物科技公司	人胚胎干细胞向胰腺内分泌细胞的分化
EP3466964A1 (en)	2012-07-06	2019-04-10	3-D Matrix Ltd.	Fill-finish process for peptide solutions
JP6282270B2 (ja)	2012-07-09	2018-02-21	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	組み換えにより生成されたパエニバシラス・ポリミキサに由来する中性プロテアーゼ
WO2014011402A1 (en)	2012-07-13	2014-01-16	Lifecell Corporation	Methods for improved treatment of adipose tissue
US8960674B2 (en)	2012-07-27	2015-02-24	Bally Gaming, Inc.	Batch card shuffling apparatuses including multi-card storage compartments, and related methods
JP6433896B2 (ja)	2012-08-13	2018-12-05	シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−ＳｉｎａｉＭｅｄｉｃａｌＣｅｎｔｅｒ	組織再生のためのエキソソームおよびマイクロリボ核酸
US9901080B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse for determining the role of senescent cells in cancer
CN104955464B (zh)	2012-09-19	2020-02-28	微血管组织有限公司	用于治疗和预防组织损伤和疾病的组合物和方法
US10596202B2 (en)	2012-09-19	2020-03-24	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US9872937B2 (en)	2012-09-19	2018-01-23	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US11819522B2 (en)	2012-09-19	2023-11-21	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
ES2849440T3 (es)	2012-09-26	2021-08-18	Lifecell Corp	Tejido adiposo procesado
KR101728808B1 (ko) *	2012-09-28	2017-04-20	한국생명공학연구원	아세카이니드 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
ITTO20120859A1 (it) *	2012-10-02	2014-04-03	Univ Degli Studi Torino	Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
WO2014066649A1 (en) *	2012-10-26	2014-05-01	The Regents Of The University Of California	A strategy for engineering various 3d tissues, organoids and vasculature
US10279018B2 (en)	2012-12-03	2019-05-07	Unity Biotechnology, Inc.	Immunogenic compositions for inducing an immune response for elimination of senescent cells
US20140170748A1 (en)	2012-12-14	2014-06-19	DePuy Synthes Products, LLC	Nutrient Enriched Media for hUTC Growth
US10370644B2 (en)	2012-12-31	2019-08-06	Janssen Biotech, Inc.	Method for making human pluripotent suspension cultures and cells derived therefrom
RU2018116647A (ru)	2012-12-31	2018-10-24	Янссен Байотек, Инк.	Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки
CN105705634A (zh)	2012-12-31	2016-06-22	詹森生物科技公司	用于分化成胰腺内分泌细胞的人多能细胞的悬浮和群集
MX2015008578A (es)	2012-12-31	2015-09-07	Janssen Biotech Inc	Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9.
EP2756754B1 (de)	2013-01-17	2017-01-04	Vita 34 Ag	Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
US20140212390A1 (en) *	2013-01-30	2014-07-31	NuTech Medical, Inc.	Placental Membrane Preparation and Methods of Making and Using Same
US9763983B2 (en)	2013-02-05	2017-09-19	Anthrogenesis Corporation	Natural killer cells from placenta
WO2014164815A2 (en)	2013-03-12	2014-10-09	Allergan, Inc.	Adipose tissue combinations, devices, and uses thereof
AU2014248873B2 (en)	2013-03-13	2017-03-23	Allosource	Fascia fibrous compositions and methods for their use and manufacture
US10329529B2 (en)	2013-03-14	2019-06-25	Celularity, Inc.	Enhanced placental stem cells and uses thereof
WO2014150784A1 (en)	2013-03-15	2014-09-25	Allosource	Cell repopulated collagen matrix for soft tissue repair and regeneration
RU2539750C2 (ru) *	2013-04-09	2015-01-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Способ оценки иммуносупрессивных свойств мезенхимальных стромальных клеток человека
US20140350516A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Mechanical syringe accessory
US10016600B2 (en)	2013-05-30	2018-07-10	Neurostim Solutions, Llc	Topical neurological stimulation
US11229789B2 (en)	2013-05-30	2022-01-25	Neurostim Oab, Inc.	Neuro activator with controller
US10058572B2 (en) *	2013-08-15	2018-08-28	The Regents Of The University Of California	Placenta-derived multipotent stem cells
US9248384B2 (en)	2013-10-02	2016-02-02	Allergan, Inc.	Fat processing system
EP3068866B1 (en)	2013-11-16	2018-04-25	Terumo BCT, Inc.	Expanding cells in a bioreactor
KR102161901B1 (ko)	2013-12-06	2020-10-05	알로소스	조직의 시트를 건조하는 방법
US10314686B2 (en) *	2013-12-17	2019-06-11	Dtherapeutics, Llc	Devices, systems and methods for tissue engineering of luminal grafts
US10328058B2 (en)	2014-01-28	2019-06-25	Mayo Foundation For Medical Education And Research	Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
US9993472B2 (en)	2014-01-28	2018-06-12	Unity Biotechnology, Inc.	Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
US20170216286A1 (en)	2014-01-28	2017-08-03	Mayo Foundation For Medical Education And Research	Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
US20190269675A1 (en)	2014-01-28	2019-09-05	Buck Institute for Research and Aging	Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
WO2016179043A1 (en)	2015-05-01	2016-11-10	Dermtech, Inc.	Non-invasive skin collection system
PT3797742T (pt)	2014-02-12	2025-03-10	Genentech Inc	Aparelho para administração supra-coroidal de agente terapêutico
JP6684719B2 (ja)	2014-03-10	2020-04-22	株式会社スリー・ディー・マトリックス	ペプチド組成物の滅菌および濾過
WO2015138514A1 (en)	2014-03-10	2015-09-17	3-D Matrix, Ltd.	Self-assembling peptide compositions
WO2015148704A1 (en)	2014-03-25	2015-10-01	Terumo Bct, Inc.	Passive replacement of media
AU2014393402A1 (en) *	2014-05-07	2016-11-24	Osiris Therapeutics, Inc.	Therapeutic placental compositions, methods of making and methods of use
EP3140417B1 (en) *	2014-05-09	2021-04-21	Reelabs Private Limited	Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
CN117821369A (zh)	2014-05-16	2024-04-05	詹森生物科技公司	小分子增强胰腺内分泌细胞中的mafa表达的用途
TW201603818A (zh)	2014-06-03	2016-02-01	組織科技股份有限公司	組成物及方法
US9949874B2 (en)	2014-06-06	2018-04-24	Janssen Biotech, Inc.	Therapeutic agent delivery device with convergent lumen
US9925088B2 (en)	2014-06-06	2018-03-27	Janssen Biotech, Inc.	Sub-retinal tangential needle catheter guide and introducer
US20160000550A1 (en) *	2014-07-05	2016-01-07	Deborah Nagle	Methods for treating diseases of the colon
KR102263824B1 (ko) *	2014-07-11	2021-06-10	가부시키가이샤 메토세라	심장 세포 배양 재료
US10322028B2 (en)	2014-09-11	2019-06-18	Orbit Biomedical Limited	Method and apparatus for sensing position between layers of an eye
US10064752B2 (en)	2014-09-11	2018-09-04	Orbit Biomedical Limited	Motorized suprachoroidal injection of therapeutic agent
US10219936B2 (en)	2014-09-11	2019-03-05	Orbit Biomedical Limited	Therapeutic agent delivery device with advanceable cannula and needle
US10258502B2 (en)	2014-09-18	2019-04-16	Orbit Biomedical Limited	Therapeutic agent delivery device
WO2016044681A1 (en)	2014-09-18	2016-03-24	North Carolina State University	Mammalian lung spheroids and lung spheroid cells and uses thereof
US9504905B2 (en)	2014-09-19	2016-11-29	Bally Gaming, Inc.	Card shuffling device and calibration method
KR101613478B1 (ko) *	2014-09-22	2016-04-19	(주)안트로젠	중간엽줄기세포-하이드로겔을 함유하는 조성물 및 이의 제조방법
US20160090569A1 (en)	2014-09-26	2016-03-31	Terumo Bct, Inc.	Scheduled Feed
JP6878274B2 (ja)	2014-10-03	2021-05-26	シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−ＳｉｎａｉＭｅｄｉｃａｌＣｅｎｔｅｒ	筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム
AU2015332556B2 (en)	2014-10-14	2021-04-29	Samuel Lynch	Compositions for treating wounds
US20180280447A1 (en) *	2014-10-29	2018-10-04	Sungkwang Medical Foundation	Placenta-derived cells excreting c3 or c1r complement and composition containing same
BR112017008855A2 (pt) *	2014-10-31	2017-12-19	The Administrators Of The Tulane Educational Fund	enxerto cirúrgico para enxertar em um paciente, método de fabricação de um enxerto cirúrgico para substituir uma parte de corpo em um paciente, método de enxerto, composição, método de fornecimento de uma cobertura protetora para um ferimento superficial de pele, e método de descelularização substancial da epiderme
CN107106613B (zh)	2014-11-07	2021-07-06	胞外体干细胞株式会社	用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
JP6563492B2 (ja) *	2014-12-05	2019-08-21	メリディジェン・バイオテック・カンパニー・リミテッドＭｅｒｉｄｉｇｅｎＢｉｏｔｅｃｈＣｏ．，Ｌｔｄ．	間葉系幹細胞を区別する方法
TW201636032A (zh) *	2014-12-05	2016-10-16	健生生物科技公司	使用前驅細胞治療眼睛病況
US20170080033A1 (en) *	2014-12-16	2017-03-23	Janssen Biotech, Inc.	Treatment of retinal degeneration using progenitor cells
EP3233096A4 (en) *	2014-12-16	2018-08-22	Janssen Biotech, Inc.	Treatment of retinal degeneration using progenitor cells
EP3234109A4 (en)	2014-12-19	2018-06-27	Janssen Biotech, Inc.	Suspension culturing of pluripotent stem cells
WO2016111899A1 (en)	2015-01-05	2016-07-14	Petrucci Gary M	Methods and materials for treating lung disorders
WO2016126122A2 (ko) *	2015-02-04	2016-08-11	한양대학교 에리카산학협력단	연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
US11077301B2 (en)	2015-02-21	2021-08-03	NeurostimOAB, Inc.	Topical nerve stimulator and sensor for bladder control
WO2016138025A2 (en)	2015-02-23	2016-09-01	Tissuetech, Inc.	Apparatuses and methods for treating ophthalmic diseases and disorders
CA2977578C (en)	2015-03-04	2024-09-10	Mesoblast International Sarl	Cell culture method for mesenchymal stem cells
EP3268063A4 (en)	2015-03-10	2018-10-31	Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company	Multiple needle injector
AU2016228894B2 (en)	2015-03-11	2021-03-04	Ccs Ventures Limited	Pancreatic endocrine progenitor cell therapies for the treatment of obesity and Type 2 diabetes (T2D)
CN107405428A (zh) *	2015-03-31	2017-11-28	北卡罗来纳-查佩尔山大学	干细胞的递送载体及其用途
US10286009B2 (en) *	2015-05-16	2019-05-14	Asterias Biotherapeutics, Inc.	Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
EP3297645A4 (en)	2015-05-20	2018-12-12	Tissuetech, Inc.	Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
CA2986702C (en)	2015-05-21	2023-04-04	David Wang	Modified demineralized cortical bone fibers
US10335435B2 (en)	2015-05-22	2019-07-02	Marco Merida	Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach
WO2017004592A1 (en)	2015-07-02	2017-01-05	Terumo Bct, Inc.	Cell growth with mechanical stimuli
US10384207B2 (en)	2015-07-21	2019-08-20	Neuro Probe Incorporated	Assay apparatus and methods
WO2017019822A1 (en) *	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Pellet composition containing repair cells
WO2017019832A1 (en)	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Methods and compositions using repair cells and cationic dyes
JP6998768B2 (ja)	2015-08-28	2022-02-10	ロート製薬株式会社	Ｒｏｒ１陽性の間葉系幹細胞及びその調製方法、ｒｏｒ１陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
WO2017123312A2 (en) *	2015-09-02	2017-07-20	Regeneration Worldwide Company, Inc.	Composition and methods of using umbilical cord lining stem cells
USD797290S1 (en)	2015-10-19	2017-09-12	Spinal Surgical Strategies, Llc	Bone graft delivery tool
WO2017087759A1 (en)	2015-11-18	2017-05-26	President And Fellows Of Harvard College	Cartridge-based system for long term culture of cell clusters
WO2017095991A1 (en) *	2015-12-04	2017-06-08	Janssen Biotech, Inc.	Treatment of retinal degeneration using progenitor cells
KR20170076484A (ko) *	2015-12-24	2017-07-04	삼성전자주식회사	프로토카데린의 과발현을 이용한 노화 세포를 분리하는 방법
WO2017120092A1 (en)	2016-01-06	2017-07-13	3-D Matrix, Ltd.	Combination compositions
WO2017123662A1 (en)	2016-01-11	2017-07-20	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
CN108471736A (zh)	2016-01-14	2018-08-31	德普伊新特斯产品公司	用于冷冻保存hutc的组合物和方法
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
US10993969B2 (en)	2016-02-05	2021-05-04	Gary M. Petrucci	Methods and materials for treating nerve injuries and neurological disorders
US11458224B2 (en)	2016-03-04	2022-10-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Ovarian-derived hydrogels for biomedical and biotechnology applications
US10478553B2 (en)	2016-03-09	2019-11-19	Orbit Biomedical Limited	Apparatus for subretinal administration of therapeutic agent via a curved needle
GB201604304D0 (en)	2016-03-14	2016-04-27	Tigenix S A U	Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3223181B1 (en) *	2016-03-24	2019-12-18	Sofradim Production	System and method of generating a model and simulating an effect on a surgical repair site
WO2017173064A1 (en)	2016-03-30	2017-10-05	Asterias Biotherapeutics, Inc.	Oligodendrocyte progenitor cell compositions
AU2017246114B2 (en)	2016-04-08	2022-03-17	Allergan, Inc.	Aspiration and injection device
MA45479A (fr)	2016-04-14	2019-02-20	Janssen Biotech Inc	Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
CN109104869B (zh)	2016-04-27	2022-07-01	日本乐敦制药株式会社	表达细胞表面标记物的间充质干细胞、包含该间充质干细胞的药物组合物及其制备方法
WO2017205667A1 (en)	2016-05-25	2017-11-30	Terumo Bct, Inc.	Cell expansion
WO2017210652A1 (en)	2016-06-03	2017-12-07	Cedars-Sinai Medical Center	Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US11685883B2 (en)	2016-06-07	2023-06-27	Terumo Bct, Inc.	Methods and systems for coating a cell growth surface
US11104874B2 (en)	2016-06-07	2021-08-31	Terumo Bct, Inc.	Coating a bioreactor
US11000410B2 (en)	2016-06-17	2021-05-11	Gyroscope Therapeutics Limited	Guide apparatus for tangential entry into suprachoroidal space
US10806629B2 (en)	2016-06-17	2020-10-20	Gyroscope Therapeutics Limited	Injection device for subretinal delivery of therapeutic agent
US10646374B2 (en)	2016-06-17	2020-05-12	Orbit Biomedical Limited	Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
MA45502A (fr)	2016-06-21	2019-04-24	Janssen Biotech Inc	Génération de cellules bêta fonctionnelles dérivées de cellules souches pluripotentes humaines ayant une respiration mitochondriale glucose-dépendante et une réponse en sécrétion d'insuline en deux phases
EP3481405A1 (en)	2016-07-05	2019-05-15	Janssen Biotech, Inc.	Treatment of retinal vascular disease using progenitor cells
WO2018009428A1 (en)	2016-07-05	2018-01-11	Lifecell Corporation	Tissue matrices incorporating multiple tissue types
US20190184060A1 (en) *	2016-08-19	2019-06-20	Regentys Corporation	Extracellular matrix for tissue reconstruction of mucosal tissue
EP3515459A4 (en)	2016-09-20	2020-08-05	Cedars-Sinai Medical Center	CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS
IL301474B2 (en)	2016-11-02	2025-09-01	Axogen Corp	Dragonfly tissue grafts, methods for their preparation, and use
RU2644306C1 (ru) *	2016-11-22	2018-02-08	Общество с ограниченной ответственностью "ДЖИ-Групп"	Способ восстановления дефектов покровных тканей
WO2018125851A1 (en) *	2016-12-26	2018-07-05	Michael Moeller	Systems and methods to isolate and expand stem cells from urine
US11273072B2 (en)	2017-01-13	2022-03-15	Gyroscope Therapeutics Limited	Suprachoroidal injection device
US10772986B2 (en)	2017-01-26	2020-09-15	Allosource	Fascia fibrous compositions and methods for their use and manufacture
WO2018164228A1 (ja)	2017-03-08	2018-09-13	ロート製薬株式会社	Ｒｏｒ１陽性の間葉系幹細胞を含有する、線維症を伴う疾患の予防又は処置のための医薬組成物、及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる線維症を伴う疾患の予防又は処置方法
US11076984B2 (en)	2017-03-13	2021-08-03	Gyroscope Therapeutics Limited	Method of performing subretinal drainage and agent delivery
WO2018170394A1 (en) *	2017-03-17	2018-09-20	Rutgers, The State University Of New Jersey	Compositions and methods for wound healing
US10767164B2 (en)	2017-03-30	2020-09-08	The Research Foundation For The State University Of New York	Microenvironments for self-assembly of islet organoids from stem cells differentiation
US12234441B2 (en)	2017-03-31	2025-02-25	Terumo Bct, Inc.	Cell expansion
US11624046B2 (en)	2017-03-31	2023-04-11	Terumo Bct, Inc.	Cell expansion
CN110612344B (zh)	2017-03-31	2023-09-12	泰尔茂比司特公司	细胞扩增
EP4317422A3 (en)	2017-04-13	2024-05-01	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
CA3059910A1 (en)	2017-04-19	2018-10-25	Cedars-Sinai Medical Center	Methods and compositions for treating skeletal muscular dystrophy
US10478531B2 (en)	2017-06-22	2019-11-19	Gary M. Petrucci	Methods and materials for treating blood vessels
CA3067109A1 (en) *	2017-06-29	2019-01-03	Xintela Ab	Quality assurance of chondrocytes
EP3655545B1 (en)	2017-07-18	2023-10-18	The Research Foundation for The State University of New York	Biomarkers for intracranial aneurysm
US10251917B1 (en)	2017-09-19	2019-04-09	Gary M. Petrucci	Methods and materials for treating tumors
US11123375B2 (en)	2017-10-18	2021-09-21	Lifecell Corporation	Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US10821205B2 (en)	2017-10-18	2020-11-03	Lifecell Corporation	Adipose tissue products and methods of production
US11246994B2 (en)	2017-10-19	2022-02-15	Lifecell Corporation	Methods for introduction of flowable acellular tissue matrix products into a hand
EP3697462B1 (en)	2017-10-19	2023-07-12	LifeCell Corporation	Flowable acellular tissue matrix products and methods of production
US11629318B2 (en)	2017-10-20	2023-04-18	President And Fellows Of Harvard College	Methods for producing mature adipocytes and methods of use thereof
WO2019083995A1 (en) *	2017-10-23	2019-05-02	Cell Medicine, Inc.	MESENCHYMAL STEM CELL THERAPY OF LEIGH SYNDROME
US20190134100A1 (en) *	2017-11-03	2019-05-09	Janssen Biotech, Inc.	Method of inhibiting angiogenesis
EP3706856A4 (en)	2017-11-07	2021-08-18	Neurostim Oab, Inc.	NON-INVASIVE NERVOUS ACTIVATOR WITH ADAPTIVE CIRCUIT
EP3727351A4 (en)	2017-12-20	2021-10-06	Cedars-Sinai Medical Center	MANIPULATED EXTRACELLULAR VESICLES FOR ENHANCED RELEASE INTO TISSUE
US11285177B2 (en)	2018-01-03	2022-03-29	Globus Medical, Inc.	Allografts containing viable cells and methods thereof
WO2019139137A1 (ja)	2018-01-12	2019-07-18	国立大学法人大阪大学	重層扁平上皮細胞の正常分化・成熟促進剤、上皮疾患治療剤及び重層扁平上皮細胞の正常分化・成熟促進方法
US20190218521A1 (en) *	2018-01-18	2019-07-18	Lorenzo Bracco	Culture medium of viruses for human vaccines have to consist of human cells from placenta and/or from umbilical cord of a fetus of the blood type 0 Rh- and of the mother of the blood type 0 Rh- (both, fetus and mother, must be of the blood type 0 Rh-)
US20200360563A1 (en) *	2018-01-30	2020-11-19	University Of Georgia Research Foundation, Inc.	Methods for Vascular Construction and Products Therefrom
WO2019152549A1 (en)	2018-02-05	2019-08-08	Cedars-Sinai Medical Center	Methods for therapeutic use of exosomes and y-rnas
CN108384752A (zh) *	2018-02-13	2018-08-10	中国人民解放军第四五五医院	成软骨培养基及其在微分裂技术中膝关节软骨分化中的应用
US12453743B2 (en)	2018-05-30	2025-10-28	Direct Biologics, Llc	Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
CN108961233A (zh) *	2018-06-28	2018-12-07	华侨大学	一种聚晶金刚石复合片表面缺陷分类识别方法
AU2019342741B2 (en)	2018-09-19	2025-12-11	Lineage Cell Therapeutics, Inc.	Methods for differentiating pluripotent stem cells in dynamic suspension culture
US11419898B2 (en)	2018-10-17	2022-08-23	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
US10993967B2 (en)	2018-10-17	2021-05-04	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
AU2020210757A1 (en)	2019-01-23	2021-08-05	Asterias Biotherapeutics, Inc.	Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
WO2020161748A1 (en)	2019-02-08	2020-08-13	Regrow Biosciences Private Limited	Method for mesenchymal stem cell isolation and osteoblast differentiation
US11759355B1 (en)	2019-02-26	2023-09-19	Gyroscope Therapeutics Limited	Method of delivering leading blebs and agent to subretinal space
KR102169924B1 (ko) *	2019-03-26	2020-10-26	연세대학교 산학협력단	연골세포 분화 유도용 조성물 및 이의 용도
KR102167257B1 (ko) *	2019-05-28	2020-10-19	부산대학교 산학협력단	토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법
EP3976127B1 (en)	2019-05-30	2025-09-24	LifeCell Corporation	Biologic breast implant
CA3144957A1 (en)	2019-06-26	2020-12-30	Neurostim Technologies Llc	Non-invasive nerve activator with adaptive circuit
EP3999083A4 (en)	2019-07-18	2023-07-26	Direct Biologics LLC	Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
WO2021039943A1 (ja) *	2019-08-29	2021-03-04	味の素株式会社	間葉系幹細胞を含む生体由来細胞試料から間葉系幹細胞を製造する方法
US20220330530A1 (en) *	2019-09-13	2022-10-20	The University Of North Carolina At Chapel Hill	Method of making human mouse xenografts
KR20220080145A (ko) *	2019-10-07	2022-06-14	유니버시티 오브 유타 리서치 파운데이션	연골원성 인간 중간엽 줄기 세포 (msc) 시트
KR102623662B1 (ko)	2019-10-11	2024-01-12	자이로스코프 테라퓨틱스 리미티드	주사기를 위한 투여 클립 조립체
WO2021092199A1 (en)	2019-11-08	2021-05-14	Kansas State University Research Foundation	Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
TWI776276B (zh) *	2019-11-13	2022-09-01	中國醫藥大學	異種組織細胞組合物治療癌症之用途
JP2023506713A (ja)	2019-12-16	2023-02-20	ニューロスティムテクノロジーズエルエルシー	昇圧電荷送達を用いた非侵襲性神経アクティベータ
AU2021267900A1 (en)	2020-05-08	2023-01-19	Gallant Pet Inc.	Uterine-derived regenerative cell compositions and uses thereof
CN111718410B (zh) *	2020-06-05	2022-10-11	江南大学	一种制备卵黄免疫球蛋白的方法
JP6967308B1 (ja) *	2020-06-30	2021-11-17	国立大学法人高知大学	胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN113755432B (zh) *	2020-07-17	2022-06-10	上海我武干细胞科技有限公司	干细胞培养方法
WO2022046954A1 (en) *	2020-08-25	2022-03-03	Celularity Inc.	Appl cells improved placental-derived adherent cells and methods of their use
CN114246985A (zh) *	2020-09-25	2022-03-29	华东理工大学	一种类骨膜组织的仿生构建方法
US12347100B2 (en)	2020-11-19	2025-07-01	Mazor Robotics Ltd.	Systems and methods for generating virtual images
EP4259053A1 (en)	2020-12-22	2023-10-18	Gyroscope Therapeutics Limited	Ocular cannula guide
CA3200810A1 (en) *	2021-01-12	2022-07-21	Jaeseung Lim	Method for screening neuronal regeneration-promoting cells having neuronal regeneration activity
CN116802501A (zh) *	2021-01-12	2023-09-22	雪拉托兹治疗株式会社	具有神经元再生活性的神经元再生促进细胞的筛选方法
WO2022204315A1 (en)	2021-03-23	2022-09-29	Terumo Bct, Inc.	Cell capture and expansion
US20250049981A1 (en) *	2021-12-17	2025-02-13	Solventum Intellectual Properties Company	Wound Dressings and Methods of Making the Same
US12209689B2 (en)	2022-02-28	2025-01-28	Terumo Kabushiki Kaisha	Multiple-tube pinch valve assembly
US12435312B2 (en)	2022-02-28	2025-10-07	Brown University	Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model
CN115068438B (zh) *	2022-04-28	2023-09-22	浙江大学医学院附属邵逸夫医院	破骨细胞前体同源靶向的细胞膜纳米囊泡制备方法及应用
ES2956802B2 (es) *	2022-05-20	2025-10-02	Bioiberica S A U	Hidrogeles para su uso en ingenieria de tejidos de la piel
CN115044542B (zh) *	2022-06-30	2023-09-26	上海市东方医院（同济大学附属东方医院）	Sj000291942在诱导间充质干细胞成骨分化方面的应用
US20250339584A1 (en) *	2022-07-26	2025-11-06	Osaka University	Composition for cartilage repair and method for manufacturing same
USD1099116S1 (en)	2022-09-01	2025-10-21	Terumo Bct, Inc.	Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
IL319330A (en)	2022-09-06	2025-05-01	Genentech Inc	A device for subretinal administration of a therapeutic agent using a double curved needle
EP4627063A1 (en)	2022-11-30	2025-10-08	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
EP4379046A1 (en)	2022-11-30	2024-06-05	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
CN116218769B (zh) *	2023-01-03	2025-09-05	深圳市汉科生物工程有限公司	一种促进软骨细胞生长的方法
CN120513071A (zh)	2023-01-13	2025-08-19	基因泰克公司	用于注射器的剂量对接座
WO2024172859A1 (en) *	2023-02-17	2024-08-22	Spine Biopharma, Inc.	Peptide formulations
TW202529711A (zh)	2023-09-29	2025-08-01	美商建南德克公司	眼插管導引器、施用器及標記器械
WO2025080727A1 (en) *	2023-10-10	2025-04-17	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Autologous serum insert for treating an ocular condition
WO2025207699A1 (en)	2024-03-27	2025-10-02	Genentech, Inc.	Torque ring for subretinal injection device

Family Cites Families (326)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US229971A (en)		1880-07-13		Ttornets
US2324800A (en) *	1941-08-14	1943-07-20	Pfizer Charles & Co	Purification of riboflavin
US2654735A (en)	1949-07-29	1953-10-06	Us Vitamin Corp	Process for the production of derivatives of 9-polyhydroxyalkylisoalloxazines and products obtained
US2864848A (en)	1954-07-19	1958-12-16	Ca Nat Research Council	Method of producing l-alpha-glycerylphosphorylcholine
US2912332A (en)	1958-02-27	1959-11-10	Swift & Co	Stabilized thiamine composition and method of enriching food products
US3665061A (en) *	1969-07-16	1972-05-23	United States Banknote Corp	Process for producing collagen sponges
JPS5651747B2 (pl)	1973-05-31	1981-12-08
CH635748A5 (fr) *	1977-08-16	1983-04-29	Cellorgan Laboratoires Sa	Procede d'obtention de cellules placentaires de brebis.
US4216144A (en) *	1977-10-20	1980-08-05	Ashmead H H	Soluble iron proteinates
JPS6040439B2 (ja) *	1978-03-29	1985-09-11	大正製薬株式会社	ヒドロコルチゾン誘導体
US4352883A (en)	1979-03-28	1982-10-05	Damon Corporation	Encapsulation of biological material
US4393240A (en)	1981-07-06	1983-07-12	Stille John K	Optically active phosphines
US4544516A (en)	1982-07-28	1985-10-01	Battelle Development Corporation	Collagen orientation
US4465776A (en) *	1982-09-27	1984-08-14	Research Corporation	Monoclonal antibodies to vitamin B6 and immunoassay method
US4657866A (en) *	1982-12-21	1987-04-14	Sudhir Kumar	Serum-free, synthetic, completely chemically defined tissue culture media
US4487865A (en)	1983-12-15	1984-12-11	Biomatrix, Inc.	Polymeric articles modified with hyaluronate
US5266480A (en) *	1986-04-18	1993-11-30	Advanced Tissue Sciences, Inc.	Three-dimensional skin culture system
US4963489A (en)	1987-04-14	1990-10-16	Marrow-Tech, Inc.	Three-dimensional cell and tissue culture system
US5863531A (en)	1986-04-18	1999-01-26	Advanced Tissue Sciences, Inc.	In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US4925667A (en) *	1986-05-27	1990-05-15	Qmax Technology Group, Inc.	Substrate with particulate cosmetic
CA1322262C (en)	1987-06-26	1993-09-21	Yoshito Ikada	Artificial skin
NZ226750A (en)	1987-10-29	1990-09-26	Amrad Corp Ltd	Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5192553A (en)	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5004681B1 (en) *	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5162405A (en) *	1987-12-24	1992-11-10	Elf Atochem North America, Inc.	Single-functional and mixtures of multi-functional oligomeric performance additive compositions and their uses
GB8803697D0 (en)	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US4963439A (en)	1988-04-19	1990-10-16	Ube Industries, Ltd.	Continuous fiber-reinforced Al-Co alloy matrix composite
US20030032178A1 (en)	1988-08-04	2003-02-13	Williams Robert Lindsay	In vitro propagation of embryonic stem cells
US5618670A (en) *	1988-08-26	1997-04-08	The United States Of America As Represented By The Department Of Health & Human Services	Detection method for c-raf-1 genes
US4925677A (en)	1988-08-31	1990-05-15	Theratech, Inc.	Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
JPH06104061B2 (ja)	1989-02-10	1994-12-21	花王株式会社	細胞培養支持体材料
US5284766A (en)	1989-02-10	1994-02-08	Kao Corporation	Bed material for cell culture
US4994602A (en) *	1989-02-27	1991-02-19	Takasago International Corporation	Process for preparing optically active 6-t-butyoxy-3,5-dihydroxyhexanoic esters
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5437994A (en) *	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5574205A (en)	1989-07-25	1996-11-12	Cell Genesys	Homologous recombination for universal donor cells and chimeric mammalian hosts
US5840580A (en)	1990-05-01	1998-11-24	Becton Dickinson And Company	Phenotypic characterization of the hematopoietic stem cell
US5145770A (en) *	1990-06-04	1992-09-08	Biosurface Technology, Inc.	Cryopreservation of cultured epithelial sheets
AU664976B2 (en)	1990-08-29	1995-12-14	Gene Pharming Europe Bv	Homologous recombination in mammalian cells
US5336616A (en) *	1990-09-12	1994-08-09	Lifecell Corporation	Method for processing and preserving collagen-based tissues for transplantation
US5342761A (en)	1990-10-01	1994-08-30	Research Development Foundation	Oncofetal gene, gene product and uses therefor
US5506134A (en)	1990-10-22	1996-04-09	Corvas International, Inc.	Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5811094A (en)	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en)	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5140100A (en) *	1990-12-28	1992-08-18	Cedars-Sinai Medical Center	Protein that inhibits production of human choriogonadotropin
US5286632A (en) *	1991-01-09	1994-02-15	Jones Douglas H	Method for in vivo recombination and mutagenesis
NL9100038A (nl) *	1991-01-11	1992-08-03	Stamicarbon	Enzym-gekatalyseerde bereiding van optisch aktieve carbonzuren.
ATE217796T1 (de)	1991-05-02	2002-06-15	Yeda Res & Dev	Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen
US6399369B1 (en) *	1991-07-08	2002-06-04	Neurospheres Holdings Ltd.	Multipotent neural stem cell cDNA libraries
WO1993003139A1 (fr)	1991-08-08	1993-02-18	Kao Corporation	Support pour la culture de cellules, production de ce support et production d'un amas de cellules au moyen de ce support
EP0529751A1 (en)	1991-08-09	1993-03-03	W.R. Grace & Co.-Conn.	Cell culture substrate, test material for cell culture and preparations thereof
AU2515992A (en)	1991-08-20	1993-03-16	Genpharm International, Inc.	Gene targeting in animal cells using isogenic dna constructs
WO1993006726A1 (en) *	1991-09-30	1993-04-15	Mackenzie Walser	Methods for treatment of free-radical-mediated tissue injury
US5308763A (en) *	1991-10-01	1994-05-03	The Johns Hopkins University	Method of making primary culture of olfactory neurons
US5914265A (en) *	1992-04-30	1999-06-22	Baylor College Of Medicine	Keratin K1 expression vectors and methods of use
AU4543193A (en)	1992-06-22	1994-01-24	Henry E. Young	Scar inhibitory factor and use thereof
US5320962A (en)	1992-07-22	1994-06-14	Duke University	DNA encoding the human A1 adenosine receptor
US5589376A (en)	1992-07-27	1996-12-31	California Institute Of Technology	Mammalian neural crest stem cells
US5356807A (en) *	1992-09-08	1994-10-18	Cornell Research Foundation	Cultured cell line of adult diploid cells from human brain and meningeal tissue
US20040224409A1 (en)	1992-09-25	2004-11-11	Laurent Pradier	Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
AU673865B2 (en)	1992-10-29	1996-11-28	Australian National University, The	Angiogenesis inhibitory antibodies
US5670483A (en)	1992-12-28	1997-09-23	Massachusetts Insititute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en)	1992-12-28	1999-09-21	Massachusetts Institute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5707643A (en) *	1993-02-26	1998-01-13	Santen Pharmaceutical Co., Ltd.	Biodegradable scleral plug
US5494899A (en) *	1993-04-07	1996-02-27	Oklahoma Medical Research Foundation	Selective regulation of B lymphocyte precursors by hormones
WO1994025584A1 (en)	1993-04-28	1994-11-10	Johns Hopkins University School Of Medicine	Chronic endothelial cell culture under flow
IL110589A0 (en)	1993-08-10	1994-11-11	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF- beta family
JP3680114B2 (ja)	1993-09-17	2005-08-10	敏一中村	脳神経障害治療剤
US6686198B1 (en)	1993-10-14	2004-02-03	President And Fellows Of Harvard College	Method of inducing and maintaining neuronal cells
US6432711B1 (en)	1993-11-03	2002-08-13	Diacrin, Inc.	Embryonic stem cells capable of differentiating into desired cell lines
US5456835A (en) *	1993-11-08	1995-10-10	Hemasure, Inc.	Device and process for removing free hemoglobin from blood
DE4406073A1 (de) *	1994-02-24	1995-08-31	Univ Ludwigs Albert	Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten
US5698518A (en)	1994-03-30	1997-12-16	Oklahoma Medical Research Foundation	Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US5466233A (en)	1994-04-25	1995-11-14	Escalon Ophthalmics, Inc.	Tack for intraocular drug delivery and method for inserting and removing same
US6001647A (en)	1994-04-28	1999-12-14	Ixion Biotechnology, Inc.	In vitro growth of functional islets of Langerhans and in vivo uses thereof
US5834308A (en)	1994-04-28	1998-11-10	University Of Florida Research Foundation, Inc.	In vitro growth of functional islets of Langerhans
US6703017B1 (en)	1994-04-28	2004-03-09	Ixion Biotechnology, Inc.	Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
AU686823B2 (en)	1994-06-06	1998-02-12	Case Western Reserve University	Biomatrix for tissue regeneration
IL114397A0 (en)	1994-07-01	1995-10-31	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF-beta-family
US5935849A (en) *	1994-07-20	1999-08-10	Cytotherapeutics, Inc.	Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5660982A (en) *	1994-10-04	1997-08-26	Tryggvason; Karl	Laminin chains: diagnostic uses
US5789147A (en)	1994-12-05	1998-08-04	New York Blood Center, Inc.	Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5725493A (en) *	1994-12-12	1998-03-10	Avery; Robert Logan	Intravitreal medicine delivery
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en)	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US5718922A (en) *	1995-05-31	1998-02-17	Schepens Eye Research Institute, Inc.	Intravitreal microsphere drug delivery and method of preparation
US5869079A (en) *	1995-06-02	1999-02-09	Oculex Pharmaceuticals, Inc.	Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5693332C1 (en)	1995-08-11	2001-01-09	Univ California	Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5641750A (en)	1995-11-29	1997-06-24	Amgen Inc.	Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US6200606B1 (en) *	1996-01-16	2001-03-13	Depuy Orthopaedics, Inc.	Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en)	1996-02-21	1998-12-01	Advanced Tissue Sciences, Inc.	Method for repairing cartilage
US6413735B1 (en)	1996-03-15	2002-07-02	Munin Corporation	Method of screening for a modulator of angiogenesis
US6223188B1 (en) *	1996-04-10	2001-04-24	Sun Microsystems, Inc.	Presentation of link information as an aid to hypermedia navigation
EP0953040A4 (en)	1996-04-26	2001-12-12	Univ Case Western Reserve	REGENERATION OF THE SKIN USING MESENCHYMAL STEM CELLS
US6358737B1 (en)	1996-07-31	2002-03-19	Board Of Regents, The University Of Texas System	Osteocyte cell lines
US6787355B1 (en)	1996-08-26	2004-09-07	Mcgill University	Multipotent neural stem cells from peripheral tissues and uses thereof
US5919702A (en)	1996-10-23	1999-07-06	Advanced Tissue Science, Inc.	Production of cartilage tissue using cells isolated from Wharton's jelly
US6541028B1 (en) *	1997-01-17	2003-04-01	Celadon Science, Llc	Methods for promoting healing of corneal resurfacing wounds
WO1998033515A1 (en)	1997-02-05	1998-08-06	Case Western Reserve University	STIMULATORY EFFECTS OF bFGF AND BMP-2 ON OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
EP0989855A4 (en)	1997-05-13	2002-06-12	Osiris Therapeutics Inc	REGENERATION OF CARTILAGE IN OSTEOARTHRITIS BY MEANS OF HUMAN MESENCHYMAL STEM CELLS
CA2290381A1 (en)	1997-05-21	1998-11-26	Sloan-Kettering Institute For Cancer Research	Method for increasing the concentration of ascorbic acid in brain tissues of a subject
DE69840171D1 (de) *	1997-05-30	2008-12-11	Osteobiologics Inc	Faserverstärkte,poröse,biologisch abbaubare implantatvorrichtung
ATE307195T1 (de)	1997-07-14	2005-11-15	Osiris Therapeutics Inc	Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
US5902598A (en)	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
ATE478135T1 (de)	1997-12-02	2010-09-15	Artecel Sciences Inc	Differenzierung in osteoblasten der fettgewebe- stromalen zellen und ihre verwendungen
US6059968A (en) *	1998-01-20	2000-05-09	Baxter International Inc.	Systems for processing and storing placenta/umbilical cord blood
US6291240B1 (en)	1998-01-29	2001-09-18	Advanced Tissue Sciences, Inc.	Cells or tissues with increased protein factors and methods of making and using same
CA2323073C (en)	1998-03-13	2010-06-22	Osiris Therapeutics, Inc.	Uses for human non-autologous mesenchymal stem cells
AU755273B2 (en)	1998-03-16	2002-12-05	Cytovia, Inc.	Dipeptide caspase inhibitors and the use thereof
US6179872B1 (en) *	1998-03-17	2001-01-30	Tissue Engineering	Biopolymer matt for use in tissue repair and reconstruction
US6171610B1 (en)	1998-04-24	2001-01-09	University Of Massachusetts	Guided development and support of hydrogel-cell compositions
AU3888699A (en)	1998-05-07	1999-11-23	University Of South Florida	Bone marrow cells as a source of neurons for brain and spinal cord repair
DE69936720T2 (de)	1998-05-29	2008-04-30	Osiris Therapeutics, Inc.	Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen
US6323188B1 (en) *	1998-07-01	2001-11-27	Donald L. Weissman	Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
DE19833340A1 (de)	1998-07-24	2000-02-10	Karlsruhe Forschzent	Wurmförmiger Arbeitsmechanismus
US20040037818A1 (en)	1998-07-30	2004-02-26	Brand Stephen J.	Treatment for diabetes
EP1105460B1 (en)	1998-08-10	2009-10-07	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
US5958767A (en)	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
US6284245B1 (en)	1998-08-25	2001-09-04	Diacrin, Inc.	Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
US6444205B2 (en)	1998-09-30	2002-09-03	Diacrin, Inc.	Transplantation of neural cells for the treatment of chronic pain or spasticity
US6610540B1 (en)	1998-11-18	2003-08-26	California Institute Of Technology	Low oxygen culturing of central nervous system progenitor cells
US6241369B1 (en) *	1998-11-20	2001-06-05	Cooper Technologies Company	Quick mount fixture
US6144054A (en) *	1998-12-04	2000-11-07	International Business Machines Corporation	DRAM cell having an annular signal transfer region
DE19856428C1 (de) *	1998-12-08	2000-05-04	Heraeus Noblelight Gmbh	Entladungslampe
HK1041454B (en)	1998-12-24	2004-12-31	生物安全股份有限公司	Blood separation system particularly for concentrating hematopoietic stem cells
JP4932069B2 (ja)	1999-01-25	2012-05-16	株式会社セルシード	アクリルアミド誘導体および該誘導体を含む重合体
CA2359821A1 (en)	1999-02-04	2000-08-10	Mcgill University	Platform for the differentiation of cells
US6326201B1 (en)	1999-02-10	2001-12-04	Curis, Inc.	Pancreatic progenitor cells, methods and uses related thereto
US6592623B1 (en)	1999-08-31	2003-07-15	Virginia Commonwealth University Intellectual Property Foundation	Engineered muscle
IL145002A0 (en)	1999-03-10	2002-06-30	Univ Pittsburgh	Adipose-derived stem cells and lattices
US20030007954A1 (en)	1999-04-12	2003-01-09	Gail K. Naughton	Methods for using a three-dimensional stromal tissue to promote angiogenesis
JP2002542339A (ja) *	1999-04-16	2002-12-10	ダブリューエム・マーシュ・ライス・ユニバーシティー	機能化されたポリ（プロピレンフマラート）及び（プロピレンフマラート−エチレングリコール）コポリマー
US7371400B2 (en)	2001-01-02	2008-05-13	The General Hospital Corporation	Multilayer device for tissue engineering
US6261600B1 (en)	1999-04-30	2001-07-17	Drugtech Corporation	Folic acid supplement
US6287340B1 (en)	1999-05-14	2001-09-11	Trustees Of Tufts College	Bioengineered anterior cruciate ligament
US6372494B1 (en)	1999-05-14	2002-04-16	Advanced Tissue Sciences, Inc.	Methods of making conditioned cell culture medium compositions
WO2000073421A2 (en)	1999-06-02	2000-12-07	Lifebank Services, L.L.C.	Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
US6329904B1 (en) *	1999-06-11	2001-12-11	Safety Through Cellular, Inc.	Apparatus and method for providing weather and other alerts
US6261841B1 (en) *	1999-06-25	2001-07-17	The Board Of Trustees Of Northwestern University	Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
US6333029B1 (en)	1999-06-30	2001-12-25	Ethicon, Inc.	Porous tissue scaffoldings for the repair of regeneration of tissue
US7621606B2 (en) *	2001-08-27	2009-11-24	Advanced Cell Technology, Inc.	Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
US6355699B1 (en)	1999-06-30	2002-03-12	Ethicon, Inc.	Process for manufacturing biomedical foams
PT1226233E (pt)	1999-08-05	2011-10-04	Abt Holding Co	Células estaminais adultas multipotentes e métodos para isolamento
US6429013B1 (en)	1999-08-19	2002-08-06	Artecel Science, Inc.	Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en)	1999-08-19	2003-04-29	Artecel Sciences, Inc.	Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
WO2001019379A2 (en)	1999-09-14	2001-03-22	Children's Medical Center Corporation, The	Methods for treating muscular dystrophy with bone marrow cells
US6331313B1 (en)	1999-10-22	2001-12-18	Oculex Pharmaceticals, Inc.	Controlled-release biocompatible ocular drug delivery implant devices and methods
US20030129745A1 (en)	1999-10-28	2003-07-10	Robl James M.	Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
EP1099754A1 (en)	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchymal stem cells and/or progenitor cells, their isolation and use
US20020164307A1 (en)	1999-12-06	2002-11-07	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
AU778929B2 (en)	1999-12-06	2004-12-23	General Hospital Corporation, The	Pancreatic stem cells and their use in transplantation
US20030082155A1 (en) *	1999-12-06	2003-05-01	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US7785882B2 (en)	2000-01-18	2010-08-31	Cornell Research Foundation, Inc.	Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them
US7544509B2 (en) *	2000-01-24	2009-06-09	Mcgill University	Method for preparing stem cell preparations
US6610535B1 (en)	2000-02-10	2003-08-26	Es Cell International Pte Ltd.	Progenitor cells and methods and uses related thereto
WO2001059072A1 (en)	2000-02-11	2001-08-16	Philadelphia Health And Education Corporation	Differentiation of bone marrow cells into neuronal cells and uses therefor
AU2001234998B2 (en)	2000-02-11	2006-06-08	Childrens Hospital Of Orange County A California Corporation	Isolation and transplantation of retinal stem cells
AU2001245550A1 (en) *	2000-03-09	2001-09-17	Lee Walters	Applications of immune system tolerance to treatment of various diseases
WO2001066698A1 (en) *	2000-03-09	2001-09-13	Cryo-Cell International, Inc.	Human cord blood as a source of neural tissue for repair of the brain and spinal cord
EP2298858A1 (en)	2000-03-16	2011-03-23	Cellseed Inc.	Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom
US6436704B1 (en)	2000-04-10	2002-08-20	Raven Biotechnologies, Inc.	Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US6673606B1 (en)	2000-04-12	2004-01-06	The Children's Hospital Of Philadelphia	Therapeutic uses for mesenchymal stromal cells
US6375972B1 (en)	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
JP2004511209A (ja)	2000-05-12	2004-04-15	ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション	細胞の脱分化及び組織の再生のための組成物及び方法
US8273570B2 (en)	2000-05-16	2012-09-25	Riken	Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
US7049072B2 (en)	2000-06-05	2006-05-23	University Of South Florida	Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
US6759039B2 (en)	2000-06-30	2004-07-06	Amcyte, Inc.	Culturing pancreatic stem cells having a specified, intermediate stage of development
ES2369253T3 (es)	2000-07-21	2011-11-28	Cellseed Inc.	Lámina celular epidérmica cultivada, lámina cutánea cultivada multicapa y proceso para producir las mismas.
ES2357764T3 (es)	2000-07-21	2011-04-29	Cellseed Inc.	Lámina celular de tipo muscular cardiaco, constructo tridimensional, tejido de tipo muscular cardiaco y proceso para producir los mismos.
US6984522B2 (en)	2000-08-03	2006-01-10	Regents Of The University Of Michigan	Isolation and use of solid tumor stem cells
DE10038814A1 (de) *	2000-08-09	2002-02-21	Abb Research Ltd	Hochspannungs-Gleichstromwandler
WO2002026941A2 (en)	2000-09-29	2002-04-04	Kooy Derek V D	Primitive neural stem cells and method for differentiation of stem cells to neural cells
US6639470B1 (en)	2000-10-06	2003-10-28	Skyworks Solutions, Inc.	Constant current biasing circuit for linear power amplifiers
US7560280B2 (en)	2000-11-03	2009-07-14	Kourion Therapeutics Gmbh	Human cord blood derived unrestricted somatic stem cells (USSC)
WO2002036749A2 (en)	2000-11-06	2002-05-10	The Salk Institute For Biological Studies	Postmortem stem cells
JP2004532648A (ja)	2000-11-30	2004-10-28	ステムロンインコーポレイテッド	単離されたホモ接合性幹細胞、これ由来の分化細胞、ならびにこれを作製及び使用するための材料及び方法
CA2430989A1 (en)	2000-12-06	2002-06-13	Robert J. Hariri	Method of collecting placental stem cells
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6599323B2 (en)	2000-12-21	2003-07-29	Ethicon, Inc.	Reinforced tissue implants and methods of manufacture and use
WO2002059278A2 (en)	2001-01-24	2002-08-01	The Government Of The United States Of America, As Represented By The Secretary Of Department Of Health & Human Services	Differentiation of stem cells to pancreatic endocrine cells
WO2002061053A1 (en)	2001-01-31	2002-08-08	The General Hospital Corporation	Renal stem cells and uses thereof
WO2002062969A2 (en)	2001-02-06	2002-08-15	Massachusetts Institute Of Technology	Cellular reprogramming in peptide hydrogel and uses thereof
US7449180B2 (en)	2001-02-06	2008-11-11	John Kisiday	Macroscopic scaffold containing amphiphilic peptides encapsulating cells
EP2336300B1 (en)	2001-02-14	2015-07-08	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
CA2796875A1 (en) *	2001-02-14	2002-08-22	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
EP1367899A4 (en)	2001-02-14	2004-07-28	Leo T Furcht	TOTIPOTENT ADULT STEM CELLS, SOURCES OF SUCH CELLS, METHODS FOR OBTAINING AND MAINTAINING SAME, METHODS FOR DIFFERENTIATING THESE CELLS, METHODS OF USING SAME, AND CELLS DERIVED FROM THE ABOVE-MENTIONED CELLS
WO2002077199A2 (en) *	2001-03-27	2002-10-03	Massachusetts Institute Of Technology	Methods and products related to fgf dimerization
US7838292B1 (en)	2001-03-29	2010-11-23	University Of Louisville Research Foundation, Inc.	Methods for obtaining adult human olfactory progenitor cells
WO2002079457A1 (en)	2001-03-29	2002-10-10	Ixion Biotechnology, Inc.	Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
US20050054102A1 (en)	2001-04-19	2005-03-10	Anna Wobus	Method for differentiating stem cells into insulin-producing cells
KR100762261B1 (ko)	2001-04-27	2007-10-04	(주)바이오니아	전장 상보 디옥시리보핵산 제조 방법과 이에 사용되는앵커와 프라이머
US20030211605A1 (en)	2001-05-01	2003-11-13	Lee Sang-Hun	Derivation of midbrain dopaminergic neurons from embryonic stem cells
US20030022369A1 (en)	2001-05-18	2003-01-30	Helen Fillmore	Differentiation of specialized dermal and epidermal cells into neuronal cells
US20030032183A1 (en) *	2001-05-25	2003-02-13	Sheridan Steven D.	Stem cell differentiation
CA2452865A1 (en)	2001-06-07	2002-12-12	Skinmedica, Inc.	Conditioned cell culture media and uses thereof
RU2183966C1 (ru)	2001-07-06	2002-06-27	Общество с ограниченной ответственностью "Сибларекс"	Состав биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий и способ получения биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий
US6402263B1 (en)	2001-07-24	2002-06-11	Robert Bosch Corporation	Dual actuation master cylinder
AU2002324645C1 (en)	2001-08-08	2008-11-06	Levesque Biosciences, Inc.	Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
US20030211603A1 (en)	2001-08-14	2003-11-13	Earp David J.	Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
US20030104997A1 (en)	2001-09-05	2003-06-05	Black Ira B.	Multi-lineage directed induction of bone marrow stromal cell differentiation
CN1195055C (zh)	2001-09-06	2005-03-30	周胜利	从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
US20050064587A1 (en)	2001-09-07	2005-03-24	Lawrence Rosenberg	Pancreatic small cells and uses thereof
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
EP1298201A1 (en)	2001-09-27	2003-04-02	Cardion AG	Process for the production of cells exhibiting an islet-beta-cell-like state
US7072332B2 (en) *	2001-09-27	2006-07-04	Samsung Electronics Co., Ltd.	Soft switch using distributed firewalls for load sharing voice-over-IP traffic in an IP network
CA2461859A1 (en)	2001-09-28	2003-04-10	Es Cell International Pte Ltd	Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers
WO2003033697A1 (en) *	2001-10-18	2003-04-24	Ixion Biotechnology, Inc.	Conversion of liver stem and progenitor cells to pancreatic functional cells
US7129034B2 (en)	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
BR0213805A (pt)	2001-11-09	2005-08-16	Artecel Sciences Inc	Células estromais derivadas de tecido adiposo para diferenciação endócrina do pâncreas e usos das mesmas
WO2003054146A2 (en)	2001-11-14	2003-07-03	Northwestern University	Self-assembly and mineralization of peptide-amphiphile nanofibers
AU2002363659B2 (en)	2001-11-15	2008-09-25	Children's Medical Center Corporation	Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
JP3728750B2 (ja) *	2001-11-22	2005-12-21	ニプロ株式会社	培養皮膚及びその製造方法
CN1596130A (zh)	2001-11-28	2005-03-16	安琪士多摩奇株式会社	治疗神经退行性疾病的基因治疗药物
US6712850B2 (en)	2001-11-30	2004-03-30	Ethicon, Inc.	Porous tissue scaffolds for the repair and regeneration of dermal tissue
EP1461440B1 (en)	2001-12-04	2011-11-09	Organogenesis Inc.	Cultured cells from pancreatic islets
US20030109036A1 (en)	2001-12-06	2003-06-12	The Regents Of The University Of California	Method for differentiating islet precursor cells into beta cells
TW200301132A (en) *	2001-12-06	2003-07-01	Sankyo Co	Pharmaceutical compositions containing cells derived from human caul
GB2415432B (en) *	2001-12-07	2006-09-06	Geron Corp	Islet cells from human embryonic stem cells
WO2003050266A2 (en) *	2001-12-11	2003-06-19	Cytograft Tissue Engineering, Inc.	Tissue engineered cellular sheets, methods of making and use thereof
JP3934539B2 (ja)	2001-12-12	2007-06-20	独立行政法人科学技術振興機構	胎盤等由来の成体又は生後組織の前駆細胞
US20030113910A1 (en)	2001-12-18	2003-06-19	Mike Levanduski	Pluripotent stem cells derived without the use of embryos or fetal tissue
US7101546B2 (en)	2001-12-21	2006-09-05	Amcyte, Inc.	In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
ATE464373T1 (de)	2001-12-21	2010-04-15	Mount Sinai Hospital Corp	Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung
CA2471540A1 (en)	2001-12-28	2003-07-10	Cellartis Ab	A method for the establishment of a pluripotent human blastocyst-derived stem cell line
US7687505B2 (en)	2002-01-14	2010-03-30	Board Of Trustees Of The University Of Illinois	Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20030158089A1 (en) *	2002-01-24	2003-08-21	Xenoport, Inc.	Administrative agents via the SMVT transporter
US20030162290A1 (en)	2002-01-25	2003-08-28	Kazutomo Inoue	Method for inducing differentiation of embryonic stem cells into functioning cells
AU2003217357A1 (en)	2002-02-07	2003-09-02	The Research Foundation Of The State University Of New York	Generation of new insulin cells from progenitor cells present in adult pancreatic islets
KR20110036114A (ko) *	2002-02-13	2011-04-06	안트로제네시스 코포레이션	산후 포유류 태반으로부터 유래한 배아-유사 줄기 세포와 그 세포를 사용한 용도 및 치료방법
AU2003215297A1 (en)	2002-02-15	2003-09-09	Cornell Research Foundation, Inc.	Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
US7371719B2 (en)	2002-02-15	2008-05-13	Northwestern University	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
WO2003070922A1 (en)	2002-02-19	2003-08-28	Medipost Co., Ltd.	Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
AU2003217658A1 (en)	2002-02-22	2003-09-09	University Of Florida	Cellular trans-differentiation
US7736892B2 (en) *	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) *	2002-02-25	2003-08-28	Kansas State University Research Foundation	Cultures, products and methods using stem cells
US7150990B2 (en)	2002-03-06	2006-12-19	Reprocell, Inc.	Self-renewing pluripotent hepatic stem cells
JP2003259862A (ja)	2002-03-12	2003-09-16	Fuji Photo Film Co Ltd	細胞培養担体
AU2003221173A1 (en)	2002-03-27	2003-10-08	Asahi Kasei Kabushiki Kaisha	Placenta-origin mesenchymal cells and medicinal use thereof
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
JP2005522215A (ja)	2002-04-12	2005-07-28	セルジーン・コーポレーション	幹細胞及び前駆細胞の分化のモジュレーション、アッセイ、並びにそれらの使用
JP4136434B2 (ja)	2002-04-17	2008-08-20	進清野	インスリン産生細胞の誘導
EP1497435A4 (en)	2002-04-19	2005-07-27	Univ Pittsburgh	STEM CELLS DERIVED FROM PLAZENTA AND THEIR USES
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
AU2003239176A1 (en)	2002-04-25	2003-11-10	Wisconsin Alumni Research Foundation	Neurodegenerative disorder treatment using gdnf secreting neural cells
US20040029269A1 (en)	2002-05-07	2004-02-12	Goldman Steven A	Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
AU2003233119A1 (en)	2002-05-08	2003-11-11	Neuronova Ab	Modulation of neural stem cells with s1p or lpa receptor agonists
EP1507848A4 (en)	2002-05-28	2005-11-23	Becton Dickinson Co	EXPANSION AND TRANSDIFFERENCING OF HUMAN AZINUS CELLS
MXPA04011851A (es)	2002-05-30	2005-03-31	Celgene Corp	Metodos para utilizar inhibidores de jnk o mkk para modular diferenciacion de celula y para tratar desordenes mieloproliferativos y sindromes mielodispl??sticos.
WO2003104442A1 (en)	2002-06-07	2003-12-18	Es Cell International Pte Ltd	Methods of regulating differentiation in stem cells
WO2003104423A2 (en) *	2002-06-11	2003-12-18	Roy Ogle	Meningeal-derived stem cells
WO2004003561A1 (en)	2002-06-27	2004-01-08	Northwestern University	Peptide rod amphiphiles and self-assembly of same
US7285415B2 (en) *	2002-07-11	2007-10-23	The Regents Of The University Of California	Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
GB0216286D0 (en)	2002-07-15	2002-08-21	Univ Leeds	Network
US7390659B2 (en)	2002-07-16	2008-06-24	The Trustees Of Columbia University In The City Of New York	Methods for inducing differentiation of embryonic stem cells and uses thereof
CA2493871A1 (en)	2002-07-16	2004-01-22	Hadi Aslan	Methods of implanting mesenchymal stem cells for tissue repair and formation
CA2493363A1 (en)	2002-07-29	2004-02-05	Asahi Kasei Kabushiki Kaisha	Stem cells for treating pancreatic damage
JP2005534345A (ja)	2002-07-29	2005-11-17	エスセルインターナショナルピーティーイーリミテッド	インスリン陽性、グルコース応答性細胞の分化のための多段階方法
WO2004016747A2 (en)	2002-08-14	2004-02-26	University Of Florida	Bone marrow cell differentiation
AU2003265094A1 (en) *	2002-08-26	2004-03-11	Neuronova Ab	Method for culturing stem cells
AU2003265856A1 (en)	2002-08-28	2004-03-19	University Of Florida	Neurogenesis from hepatic stem cells
EP1539928A4 (en)	2002-09-06	2006-09-06	Amcyte Inc	POSIOTIVE PANCREATIC ENDOCRINE PROGENITOR CELLS CD56 IN ADULT HUMAN BEINGS
US6766863B2 (en) *	2002-09-20	2004-07-27	Hypro Corporation	Fire fighting foam injection system with auto-start feature
US9969977B2 (en)	2002-09-20	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US20040062753A1 (en)	2002-09-27	2004-04-01	Alireza Rezania	Composite scaffolds seeded with mammalian cells
JP4262465B2 (ja)	2002-10-24	2009-05-13	富士フイルム株式会社	細胞培養方法
WO2004039248A2 (en)	2002-10-31	2004-05-13	The General Hospital Corporation	Repairing or replacing tissues or organs
EP1583422B1 (en)	2002-12-05	2016-03-30	Case Western Reserve University	Cell-based therapies for ischemia
JP4571387B2 (ja)	2003-02-07	2010-10-27	宣男櫻川	ヒト羊膜由来サイドポピュレーション細胞及びその用途
ES2351386T3 (es)	2003-02-11	2011-02-03	John E. Davies	Células progenitoras procedentes de la gelatina de wharton de cordón umbilical humano .
JP4837553B2 (ja)	2003-02-11	2011-12-14	ノースウエスタンユニバーシティ	ナノ結晶表面被膜の方法及び材料ならびにその上へのペプチド両親媒性物質ナノ繊維の付着物
US7521481B2 (en) *	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2006019366A1 (en) *	2003-03-28	2006-02-23	Wisconsin Alumni Research Foundation	Physiochemical culture conditions for embryonic stem cells
US7960166B2 (en)	2003-05-21	2011-06-14	The General Hospital Corporation	Microfabricated compositions and processes for engineering tissues containing multiple cell types
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US20060223177A1 (en) *	2003-06-27	2006-10-05	Ethicon Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
AU2004252571C1 (en)	2003-06-27	2012-03-01	Ethicon, Incorporated	Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
CA2536909A1 (en)	2003-08-29	2005-03-10	Regents Of The University Of Minnesota	Kidney derived stem cells and methods for their isolation, differentiation and use
US20050089513A1 (en)	2003-10-28	2005-04-28	Norio Sakuragawa	Side population cells originated from human amnion and their uses
BRPI0417776A (pt) *	2003-12-23	2007-03-20	Fmc Biopolymer As	método de inibição da proliferação de uma pluralidade de células proliferativas, de inibição do crescimento de célula hospedeira em uma composição implantável em um humano e de inibição do crescimento celular em uma composição implantável em um animal, dispositivo implantável, método de inibição do crescimento celular em um dispositivo implantável, composição, e, métodos de preparação de um tecido artificial, de revestimento ou cobertura da superfìcie externa de uma composição ou dispositivo livre de células com uma uma matriz de alginato e de tratamento de um indivìduo que tem diabetes
TWI276685B (en)	2003-12-30	2007-03-21	Ind Tech Res Inst	Conditional medium for culturing Schwann cells
US7534606B2 (en)	2004-01-12	2009-05-19	National Health Research Institutes	Placental stem cell and methods thereof
DE102004043256B4 (de)	2004-09-07	2013-09-19	Rheinische Friedrich-Wilhelms-Universität Bonn	Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension
US8039258B2 (en)	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
EP1812557A4 (en)	2004-10-29	2009-11-04	Centocor Ortho Biotech Inc	COMPOSITIONS OF CHEMICALLY DEFINED MEDIA
US7655678B2 (en) *	2004-11-30	2010-02-02	Council of Scientfic & Industrial Research	Pharmaceutical composition for the management of tumors
US20060153815A1 (en) *	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
US20060166361A1 (en)	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060171930A1 (en)	2004-12-21	2006-08-03	Agnieszka Seyda	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
EP1831355A2 (en)	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
WO2006071802A2 (en)	2004-12-23	2006-07-06	Ethicon Incorporated	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
EP1838842A2 (en)	2004-12-23	2007-10-03	Ethicon, Incorporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
US7741311B2 (en)	2005-01-03	2010-06-22	Shaker Mousa	Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
EP1853698A1 (en)	2005-01-28	2007-11-14	NovaThera Ltd.	Methods for embryonic stem cell culture
CN103361301A (zh)	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	高度纯化来自羊膜的细胞群
US7923007B2 (en)	2005-08-08	2011-04-12	Academia Sinica	Brain tissue damage therapies
PL1971681T3 (pl)	2005-12-16	2018-01-31	Depuy Synthes Products Inc	Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej
ES2391034T3 (es) *	2005-12-19	2012-11-20	Ethicon, Inc.	Expansión in vitro de células derivadas postparto en frascos rotatorios
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
WO2007076522A2 (en) *	2005-12-28	2007-07-05	Ethicon, Incorporated	Treatment of peripheral vascular disease using postpartum-derived cells
KR20200123283A (ko)	2005-12-29	2020-10-28	안트로제네시스 코포레이션	태반 줄기 세포 집단
US7939645B2 (en) *	2006-01-06	2011-05-10	Agilent Technologies, Inc	Reaction buffer composition for nucleic acid replication with packed DNA polymerases
BRPI0709349A2 (pt)	2006-03-23	2011-07-12	Pluristem Ltd	métodos para expansão celular e usos de células e de meios condicionados produzidos através deles para terapia
US20080064098A1 (en) *	2006-06-05	2008-03-13	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of maternal placental cells
AU2007308168B2 (en) *	2006-10-12	2013-09-26	Ethicon, Inc.	Kidney-derived cells and methods of use in tissue repair and regeneration
WO2008060541A2 (en)	2006-11-13	2008-05-22	Ethicon, Incorporated	In vitro expansion of postpartum-derived cells using microcarriers
PT2120977E (pt) *	2007-02-12	2013-09-16	Anthrogenesis Corp	Tratamento de doenças inflamatórias utilizando células estaminais da placenta
US20080305148A1 (en)	2007-03-19	2008-12-11	National Yang Ming University	Treatment of spinal injuries using human umbilical mesenchymal stem cells
US8034329B2 (en)	2007-10-05	2011-10-11	Advanced Technologies And Regenerative Medicine, Llc	Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
US20090123620A1 (en) *	2007-11-14	2009-05-14	Hiti Thomas R	Automated Application of an Antimycotic Composition to Sliced Foodstuffs and an Antimycotic Application Apparatus
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
WO2009086215A2 (en) *	2007-12-21	2009-07-09	Wyeth	Pathway analysis of cell culture phenotypes and uses thereof
BRPI0821489A2 (pt)	2007-12-27	2015-06-16	Ethicon Inc	Tratamento de degeneração do disco intervetebral com o uso de células derivadas de tecido de cordão umbilical humano
TWI363847B (en) *	2008-03-28	2012-05-11	Ind Tech Res Inst	Light emitting device with positioning function and assembly method thereof
CA2747758C (en)	2008-12-19	2020-09-22	Ethicon, Incorporated	Regeneration and repair of neural tissue following injury
PL2379088T3 (pl)	2008-12-19	2018-07-31	DePuy Synthes Products, Inc.	Leczenie płuca oraz chorób i zaburzeń płucnych
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
PT2379087E (pt)	2008-12-19	2014-12-02	Depuy Synthes Products Llc	Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
BRPI1013409A2 (pt)	2009-03-26	2018-01-16	Advanced Tech And Regenerative Medicine Llc	células de tecido de cordão umbilical humano como terapia para doença de alzheimer
WO2012100049A1 (en) *	2011-01-19	2012-07-26	E. I. Du Pont De Nemours And Company	Lithium battery separator with shutdown function

2004
- 2004-06-25 AU AU2004252571A patent/AU2004252571C1/en not_active Ceased
- 2004-06-25 JP JP2006517757A patent/JP4950659B2/ja not_active Expired - Fee Related
- 2004-06-25 EP EP10183053.7A patent/EP2399990B1/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,012 patent/US7510873B2/en not_active Expired - Lifetime
- 2004-06-25 ES ES10184796.0T patent/ES2569780T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004252570A patent/AU2004252570C1/en not_active Ceased
- 2004-06-25 ES ES04777286.8T patent/ES2582342T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES04777234.8T patent/ES2600555T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004252566A patent/AU2004252566B2/en not_active Ceased
- 2004-06-25 JP JP2006517786A patent/JP4948164B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES04809466.8T patent/ES2565582T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020958 patent/WO2005038012A2/en not_active Ceased
- 2004-06-25 AU AU2004254616A patent/AU2004254616C1/en not_active Ceased
- 2004-06-25 CA CA2530422A patent/CA2530422C/en not_active Expired - Fee Related
- 2004-06-25 CA CA2530416A patent/CA2530416C/en not_active Expired - Fee Related
- 2004-06-25 PL PL04777287T patent/PL1641918T3/pl unknown
- 2004-06-25 ES ES10183911.6T patent/ES2552226T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004252567A patent/AU2004252567B2/en not_active Ceased
- 2004-06-25 EP EP10183911.6A patent/EP2341131B1/en not_active Expired - Lifetime
- 2004-06-25 ES ES10184137.7T patent/ES2542069T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/876,998 patent/US11191789B2/en not_active Expired - Lifetime
- 2004-06-25 EP EP04777287.6A patent/EP1641918B1/en not_active Expired - Lifetime
- 2004-06-25 EP EP04777235.5A patent/EP1641916B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530255A patent/CA2530255C/en not_active Expired - Fee Related
- 2004-06-25 EP EP04777286.8A patent/EP1641917B1/en not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020957 patent/WO2005001080A2/en not_active Ceased
- 2004-06-25 EP EP04777231.4A patent/EP1641914B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517760A patent/JP4950661B2/ja not_active Expired - Fee Related
- 2004-06-25 AU AU2004252568A patent/AU2004252568B2/en not_active Expired - Fee Related
- 2004-06-25 PL PL10184593T patent/PL2322599T3/pl unknown
- 2004-06-25 PL PL10183053T patent/PL2399990T3/pl unknown
- 2004-06-25 ES ES10184306.8T patent/ES2554343T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020956 patent/WO2005001079A2/en not_active Ceased
- 2004-06-25 ES ES10184593.1T patent/ES2542070T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10183053.7T patent/ES2550267T3/es not_active Expired - Lifetime
- 2004-06-25 PL PL04756395T patent/PL1641913T3/pl unknown
- 2004-06-25 PL PL10184221T patent/PL2338981T3/pl unknown
- 2004-06-25 AU AU2004281371A patent/AU2004281371C1/en not_active Ceased
- 2004-06-25 PL PL10183911T patent/PL2341131T3/pl unknown
- 2004-06-25 PL PL04809466T patent/PL1649013T3/pl unknown
- 2004-06-25 PL PL04777234T patent/PL1641915T3/pl unknown
- 2004-06-25 PL PL04777231T patent/PL1641914T3/pl unknown
- 2004-06-25 EP EP04756395.2A patent/EP1641913B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517759A patent/JP4950660B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES04777287.6T patent/ES2564045T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP04777234.8A patent/EP1641915B1/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,445 patent/US8703121B2/en active Active
- 2004-06-25 JP JP2006517787A patent/JP4948165B2/ja not_active Expired - Fee Related
- 2004-06-25 EP EP10184306.8A patent/EP2338982B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL10184306T patent/PL2338982T3/pl unknown
- 2004-06-25 PL PL10184796T patent/PL2336298T3/pl unknown
- 2004-06-25 CA CA2530412A patent/CA2530412C/en not_active Expired - Fee Related
- 2004-06-25 EP EP20100184137 patent/EP2338980B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL04777235T patent/PL1641916T3/pl unknown
- 2004-06-25 WO PCT/US2004/020931 patent/WO2005003334A2/en not_active Ceased
- 2004-06-25 US US10/877,269 patent/US7524489B2/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517788A patent/JP4948166B2/ja not_active Expired - Fee Related
- 2004-06-25 CA CA2530533A patent/CA2530533C/en not_active Expired - Fee Related
- 2004-06-25 ES ES04756395.2T patent/ES2564044T3/es not_active Expired - Lifetime
- 2004-06-25 CA CA2530421A patent/CA2530421C/en not_active Expired - Fee Related
- 2004-06-25 EP EP20100184221 patent/EP2338981B1/en not_active Expired - Lifetime
- 2004-06-25 EP EP10184593.1A patent/EP2322599B1/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,541 patent/US7413734B2/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517783A patent/JP5148873B2/ja not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020822 patent/WO2005001077A2/en not_active Ceased
- 2004-06-25 ES ES04777235.5T patent/ES2568463T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP10184796.0A patent/EP2336298B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL10184137T patent/PL2338980T3/pl unknown
- 2004-06-25 EP EP04809466.8A patent/EP1649013B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530732A patent/CA2530732C/en not_active Expired - Fee Related
- 2004-06-25 US US10/877,446 patent/US9579351B2/en not_active Expired - Fee Related
- 2004-06-25 US US10/877,009 patent/US7560276B2/en not_active Expired - Lifetime
- 2004-06-25 ES ES04777231.4T patent/ES2597837T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020816 patent/WO2005001076A2/en not_active Ceased
- 2004-06-25 ES ES10184221.9T patent/ES2541604T3/es not_active Expired - Lifetime
- 2004-06-25 PL PL04777286.8T patent/PL1641917T3/pl unknown
- 2004-06-25 WO PCT/US2004/020823 patent/WO2005001078A2/en not_active Ceased
2005
- 2005-12-22 US US11/316,104 patent/US9504719B2/en not_active Expired - Fee Related
- 2005-12-22 US US11/315,969 patent/US11179422B2/en not_active Expired - Lifetime
- 2005-12-23 US US11/317,574 patent/US20060234376A1/en not_active Abandoned
- 2005-12-29 US US11/321,864 patent/US20060153818A1/en not_active Abandoned
- 2005-12-29 US US11/322,003 patent/US20060154367A1/en not_active Abandoned
- 2005-12-29 US US11/321,863 patent/US20060153817A1/en not_active Abandoned
- 2005-12-30 US US11/322,372 patent/US20060188983A1/en not_active Abandoned
2006
- 2006-07-06 US US11/481,456 patent/US8318483B2/en not_active Expired - Fee Related
- 2006-07-06 US US11/481,481 patent/US20070014771A1/en not_active Abandoned
- 2006-07-06 US US11/481,480 patent/US20070009494A1/en not_active Abandoned
2009
- 2009-02-19 US US12/389,305 patent/US9498501B2/en not_active Expired - Fee Related
- 2009-04-24 US US12/429,849 patent/US8277796B2/en not_active Expired - Fee Related
2012
- 2012-09-06 US US13/605,716 patent/US8658152B2/en not_active Expired - Lifetime
2013
- 2013-09-05 US US14/018,842 patent/US9717763B2/en not_active Expired - Fee Related
2016
- 2016-11-28 US US15/362,453 patent/US10039793B2/en not_active Expired - Lifetime
2017
- 2017-02-27 US US15/443,718 patent/US10195233B2/en not_active Expired - Lifetime
- 2017-02-27 US US15/443,733 patent/US10383898B2/en not_active Expired - Fee Related
- 2017-02-27 US US15/443,602 patent/US10220059B2/en not_active Expired - Lifetime
- 2017-07-27 US US15/661,878 patent/US10500234B2/en not_active Expired - Fee Related
2018
- 2018-08-06 US US16/056,146 patent/US10758576B2/en not_active Expired - Fee Related
2019
- 2019-03-04 US US16/291,784 patent/US11000554B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2004252570B2 (en)	2011-09-15
EP1641918A2 (en)	2006-04-05
WO2005001077A2 (en)	2005-01-06
EP2341131B1 (en)	2015-08-05
CA2530255C (en)	2015-12-08
ES2542069T3 (es)	2015-07-30
PL1649013T3 (pl)	2016-07-29
JP2007528706A (ja)	2007-10-18
US20170239299A1 (en)	2017-08-24
AU2004252571C1 (en)	2012-03-01
US11000554B2 (en)	2021-05-11
EP2338980B1 (en)	2015-04-22
EP1641915A2 (en)	2006-04-05
EP1649013A2 (en)	2006-04-26
US7510873B2 (en)	2009-03-31
US9504719B2 (en)	2016-11-29
AU2004254616C1 (en)	2012-03-01
US10383898B2 (en)	2019-08-20
AU2004252571B2 (en)	2011-09-15
CA2530732A1 (en)	2005-01-06
ES2542070T3 (es)	2015-07-30
JP4950660B2 (ja)	2012-06-13
EP1641914B1 (en)	2016-07-20
ES2568463T3 (es)	2016-04-29
PL2322599T3 (pl)	2015-10-30
JP4948166B2 (ja)	2012-06-06
EP2338982A2 (en)	2011-06-29
WO2005001080A3 (en)	2005-03-24
EP1641918B1 (en)	2016-01-06
WO2005001079A2 (en)	2005-01-06
JP4950659B2 (ja)	2012-06-13
US10500234B2 (en)	2019-12-10
US10758576B2 (en)	2020-09-01
JP5148873B2 (ja)	2013-02-20
EP2322599B1 (en)	2015-04-15
ES2564045T3 (es)	2016-03-17
US11179422B2 (en)	2021-11-23
US11191789B2 (en)	2021-12-07
JP4948164B2 (ja)	2012-06-06
CA2530421A1 (en)	2005-01-06
EP2338980A3 (en)	2011-08-10
US20060153818A1 (en)	2006-07-13
PL1641917T3 (pl)	2016-11-30
AU2004252568B2 (en)	2011-06-30
JP4948165B2 (ja)	2012-06-06
PL1641915T3 (pl)	2017-01-31
PL1641913T3 (pl)	2016-06-30
EP1641916B1 (en)	2016-02-17
WO2005038012A3 (en)	2005-09-15
EP2338981A3 (en)	2011-08-03
CA2530533A1 (en)	2005-01-13
EP2341131A3 (en)	2011-08-03
US9498501B2 (en)	2016-11-22
US10039793B2 (en)	2018-08-07
ES2564044T3 (es)	2016-03-17
ES2582342T3 (es)	2016-09-12
US20170143770A1 (en)	2017-05-25
EP1641915B1 (en)	2016-07-27
CA2530421C (en)	2015-04-21
EP2322599A3 (en)	2011-07-27
EP1641916A2 (en)	2006-04-05
JP2007528703A (ja)	2007-10-18
WO2005038012A2 (en)	2005-04-28
US20100210013A1 (en)	2010-08-19
CA2530416A1 (en)	2005-01-06
US10195233B2 (en)	2019-02-05
AU2004252566B2 (en)	2011-09-15
US20140045263A1 (en)	2014-02-13
JP2007528705A (ja)	2007-10-18
ES2600555T3 (es)	2017-02-09
EP2341131A2 (en)	2011-07-06
US7560276B2 (en)	2009-07-14
EP1641913B1 (en)	2016-01-06
WO2005003334A2 (en)	2005-01-13
EP2336298A2 (en)	2011-06-22
EP2322599A2 (en)	2011-05-18
AU2004252567A1 (en)	2005-01-06
ES2597837T3 (es)	2017-01-23
WO2005001076A2 (en)	2005-01-06
US20060154366A1 (en)	2006-07-13
WO2005001077A3 (en)	2005-03-03
JP2007528702A (ja)	2007-10-18
US20050019865A1 (en)	2005-01-27
AU2004254616A1 (en)	2005-01-13
US7413734B2 (en)	2008-08-19
US7524489B2 (en)	2009-04-28
PL1641916T3 (pl)	2016-08-31
JP2007521793A (ja)	2007-08-09
WO2005003334A3 (en)	2005-04-07
AU2004281371C1 (en)	2012-10-11
WO2005001078A2 (en)	2005-01-06
JP2007521009A (ja)	2007-08-02
CA2530422A1 (en)	2005-01-06
US8703121B2 (en)	2014-04-22
US20060153816A1 (en)	2006-07-13
AU2004252567B2 (en)	2011-10-06
US20070009494A1 (en)	2007-01-11
AU2004252571A1 (en)	2005-01-06
US20170326183A1 (en)	2017-11-16
CA2530422C (en)	2016-01-05
EP1641913A2 (en)	2006-04-05
EP1641917A2 (en)	2006-04-05
CA2530255A1 (en)	2005-01-06
PL2338980T3 (pl)	2016-04-29
US10220059B2 (en)	2019-03-05
ES2554343T3 (es)	2015-12-18
US8277796B2 (en)	2012-10-02
US20050054098A1 (en)	2005-03-10
WO2005001079A3 (en)	2005-04-28
US20070036767A1 (en)	2007-02-15
US8658152B2 (en)	2014-02-25
AU2004254616B2 (en)	2011-09-01
CA2530412A1 (en)	2005-04-28
ES2552226T3 (es)	2015-11-26
EP2399990A1 (en)	2011-12-28
US20050032209A1 (en)	2005-02-10
US20060154367A1 (en)	2006-07-13
EP2336298A3 (en)	2011-08-03
AU2004281371A1 (en)	2005-04-28
PL2341131T3 (pl)	2016-01-29
PL1641914T3 (pl)	2017-01-31
AU2004252570A1 (en)	2005-01-06
EP1641914A2 (en)	2006-04-05
EP2338981A2 (en)	2011-06-29
EP2338982A3 (en)	2011-08-03
ES2550267T3 (es)	2015-11-05
WO2005001080A2 (en)	2005-01-06
EP1641917B1 (en)	2016-04-27
CA2530416C (en)	2015-08-25
AU2004252566A1 (en)	2005-01-06
US20060234376A1 (en)	2006-10-19
US20180338999A1 (en)	2018-11-29
WO2005001076A3 (en)	2005-03-31
ES2569780T3 (es)	2016-05-12
EP2338981B1 (en)	2015-04-22
US20170166863A1 (en)	2017-06-15
CA2530412C (en)	2016-02-09
CA2530533C (en)	2015-02-10
AU2004252568A1 (en)	2005-01-06
PL2336298T3 (pl)	2016-08-31
PL2399990T3 (pl)	2015-12-31
EP2336298B1 (en)	2016-02-17
US20050058629A1 (en)	2005-03-17
US20060188983A1 (en)	2006-08-24
US20060153817A1 (en)	2006-07-13
EP1649013B1 (en)	2016-01-20
JP2007521008A (ja)	2007-08-02
CA2530732C (en)	2015-03-31
US20130022585A1 (en)	2013-01-24
PL1641918T3 (pl)	2016-06-30
US20170166864A1 (en)	2017-06-15
US20190192577A1 (en)	2019-06-27
ES2541604T3 (es)	2015-07-22
WO2005001078A3 (en)	2005-04-21
PL2338981T3 (pl)	2016-01-29
AU2004252570C1 (en)	2012-03-01
US20050037491A1 (en)	2005-02-17
US20100260843A1 (en)	2010-10-14
EP2338982B1 (en)	2015-08-26
US20050058630A1 (en)	2005-03-17
EP2399990B1 (en)	2015-07-22
US20050058631A1 (en)	2005-03-17
US8318483B2 (en)	2012-11-27
JP4950661B2 (ja)	2012-06-13
EP2338980A2 (en)	2011-06-29
US20070014771A1 (en)	2007-01-18
AU2004281371B2 (en)	2012-05-10
ES2565582T3 (es)	2016-04-05
US9579351B2 (en)	2017-02-28
US9717763B2 (en)	2017-08-01

Publication	Publication Date	Title
PL2338982T3 (pl)	2016-01-29	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL1831356T3 (pl)	2017-07-31	Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania
EP1599122A4 (en)	2009-04-29	SYSTEM AND METHOD FOR NON-FEVER TISSUE CHARACTERIZATION
IL166823A0 (en)	2006-01-15	Tendon-driven endoscope and methods of insertion
PL375691A1 (pl)	2005-12-12	Imidazolopirydyny i sposoby ich wytwarzania i stosowania
EP1596656A4 (en)	2006-10-18	PYRAZOLES AND METHODS OF MAKING AND USING THEM
AU2003225705A1 (en)	2004-09-30	Cytidine analogs and methods of use
EP1571968A4 (en)	2007-10-17	COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
EP1589933A4 (en)	2011-01-26	COMPOSITIONS AND METHODS FOR DIETUMOR DIAGNOSIS AND TREATMENT
EP1626695A4 (en)	2009-12-30	COMPOSITIONS AND METHODS FOR REDUCING THE FORMATION OF SCARES
AU2003207698A8 (en)	2005-10-20	Needle-suture combinations and methods of use
EP1578996A4 (en)	2007-12-19	COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
AU2003296379A8 (en)	2004-06-30	Methods and devices for cardiac surgery
EP1572091A4 (en)	2008-03-05	COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
PL375699A1 (pl)	2005-12-12	Pirazolopirydyny i sposoby ich wytwarzania i stosowania
EP1575571A4 (en)	2008-06-25	COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR
AU2003303926A8 (en)	2004-09-06	Ceramics and methods of making the same
WO2005003154A8 (en)	2005-06-16	Compositions and methods for the diagnosis and treatment of tumor
AU2003237792A1 (en)	2004-11-23	Compositions and methods for the diagnosis and treatment of tumor
EP1651956A4 (en)	2008-08-20	MELKS AS MODIFIERS OF THE ACTION ACTION MECHANISM AND METHODS OF USE
EP1627217A4 (en)	2007-09-12	CDKL1 AS A MODIFIER FOR CONNECTION MORPHOGENESIS, AND METHODS OF USING CDKL1
WO2005052191A8 (en)	2005-09-01	Compositions and methods for the diagnosis and treatment of tumor
AU2003272390A8 (en)	2004-04-30	Ampds as modifiers of the p21 pathway and methods of use
AU2003251826A8 (en)	2004-01-23	Mp21s as modifiers of the p21 pathway and methods of use
HK1082503A (en)	2006-06-09	Triazolopyrazines and methods of making and using the same